Bioactive food compounds of Mediterranean and Nordic diets and their effects on nutritional and cardiovascular disease biomarkers by Pedret Figuerola, Anna
  
 
 
 
 
 
 
 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC 
DIETS AND THEIR EFFECTS ON NUTRITIONAL AND CARDIOVASCULAR 
DISEASE. 
     
Anna Pedret Figuerola 
 
Dipòsit Legal: T 1916-2014 
 
 
ADVERTIMENT. L'accés als continguts d'aquesta tesi doctoral i la seva utilització ha de respectar els drets 
de la persona autora. Pot ser utilitzada per a consulta o estudi personal, així com en activitats o materials 
d'investigació i docència en els termes establerts a l'art. 32 del Text Refós de la Llei de Propietat Intel·lectual 
(RDL 1/1996). Per altres utilitzacions es requereix l'autorització prèvia i expressa de la persona autora. En 
qualsevol cas, en la utilització dels seus continguts caldrà indicar de forma clara el nom i cognoms de la 
persona autora i el títol de la tesi doctoral. No s'autoritza la seva reproducció o altres formes d'explotació 
efectuades amb finalitats de lucre ni la seva comunicació pública des d'un lloc aliè al servei TDX. Tampoc 
s'autoritza la presentació del seu contingut en una finestra o marc aliè a TDX (framing). Aquesta reserva de 
drets afecta tant als continguts de la tesi com als seus resums i índexs. 
 
 
ADVERTENCIA. El acceso a los contenidos de esta tesis doctoral y su utilización debe respetar los 
derechos de la persona autora. Puede ser utilizada para consulta o estudio personal, así como en 
actividades o materiales de investigación y docencia en los términos establecidos en el art. 32 del Texto 
Refundido de la Ley de Propiedad Intelectual (RDL 1/1996). Para otros usos se requiere la autorización 
previa y expresa de la persona autora. En cualquier caso, en la utilización de sus contenidos se deberá 
indicar de forma clara el nombre y apellidos de la persona autora y el título de la tesis doctoral. No se 
autoriza su reproducción u otras formas de explotación efectuadas con fines lucrativos ni su comunicación 
pública desde un sitio ajeno al servicio TDR. Tampoco se autoriza la presentación de su contenido en una 
ventana o marco ajeno a TDR (framing). Esta reserva de derechos afecta tanto al contenido de la tesis como 
a sus resúmenes e índices. 
 
 
WARNING. Access to the contents of this doctoral thesis and its use must respect the rights of the author. It 
can be used for reference or private study, as well as research and learning activities or materials in the 
terms established by the 32nd article of the Spanish Consolidated Copyright Act (RDL 1/1996). Express and 
previous authorization of the author is required for any other uses. In any case, when using its content, full 
name of the author and title of the thesis must be clearly indicated. Reproduction or other forms of for profit 
use or public communication from outside TDX service is not allowed. Presentation of its content in a window 
or frame external to TDX (framing) is not authorized either. These rights affect both the content of the thesis 
and its abstracts and indexes. 
   
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
 UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
  
Anna Pedret Figuerola 
 
Bioactive food compounds of Mediterranean and 
Nordic diets and their effects on nutritional and 
cardiovascular disease biomarkers. 
 
INTERNATIONAL THESIS 
Supervised by Dr. Rosa Solà i Alberich 
 
PhD in Biomedicine 
Universitat Rovira i Virgili 
Department of Medicine and Surgery 
Unit of Lipids and Atherosclerosis Research 
 
 
 
 
 
Reus, Tarragona, Spain 2014 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
 UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
  
 
 
FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT 
DEPARTAMENT DE MEDICINA I CIRURGIA 
 
Carrer Sant Llorenç, 21 
43201 Reus 
Tel. 977 759 306 
Fax. 977 759 352 
 
 
 
FAIG CONSTAR: 
Que aquest treball, titulat “Bioactive food compounds of Mediterranean and 
Nordic diets and their effects on nutritional and cardiovascular disease 
biomarkers”, que presenta Anna Pedret Figuerola, ha estat realitzat sota la 
meva direcció al Departament de Medicina i Cirurgia i que acompleix els 
requeriments per a poder optar al títol de Doctor. 
 
 
Reus, 30 d’abril de 2014 
El director de la Tesi doctoral 
 
Dra. Rosa SOLÀ I ALBERICH 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
  
  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
  
 
  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Look deep into nature, and then you will understand everything better” 
Albert Einstein 
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INTRODUCTION 
Cardiovascular diseases (CVDs) are the leading cause of death globally, 
and atherosclerosis is the major biological process involved in these 
diseases. CVD biomarkers are tools used in clinical practice to identify 
individuals with a high risk of CVDs, to quickly diagnose the diseases and to 
accurately and effectively predict and treat patients. Currently, many CVD 
biomarkers already exist that help to identify vulnerable patients; however, 
the discovery of new biomarkers can provide us with valuable new 
information to understand the pathophysiology of CVDs, and to prevent and 
treat CVDs. 
Currently, numerous epidemiological studies have shown several important 
links among Mediterranean and Nordic dietary bioactive compounds (such 
as polyphenols), and the occurrence of CVDs. The poor accuracy of 
measuring the intake of foods and bioactive compounds is one of the biggest 
challenges in nutrition research. This challenge could be overcome by using 
quantifiable biomarkers of dietary intake.  
Omic technologies support detailed studies of molecular changes during 
CVD onset and progression, as well as during dietary interventions. In the 
last decade, proteomics and metabolomics have contributed substantially to 
our understanding of CVD biology and to the discovery of nutritional and 
molecular CVD biomarkers. In nutritional interventions, metabolome 
analyses focus on identifying new biomarkers that allow the intake of certain 
dietary bioactive compounds to be monitored and related to their expected 
biological effects. Moreover, recent advances in proteomic technologies 
permit the evaluation of systematic changes in protein expression in 
response to intrinsic or extrinsic perturbations to the biological system, for 
example, those changes that occur in CVDs or that occur after a dietary 
intervention. Proteomics is a key tool for exploring the molecular 
mechanisms involved in the cardioprotective activities of dietary bioactive 
compounds.  
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HYPOTHESIS  
Our hypothesis is that the intake of certain dietary bioactive compounds of 
the Mediterranean and Nordic diets can be assessed and monitored by 
nutritional biomarkers, improving the accuracy of the dietary intake measure. 
Moreover, these dietary bioactive compounds could be associated with an 
important diversity of mechanisms of action and with healthy biological 
effects on molecular biomarkers involved in the development of CVDs, in 
both healthy and CVD risk subjects. 
OBJECTIVES 
The primary objective is to assess the effect of Mediterranean and Nordic 
dietary bioactive compounds, particularly phenolic compounds, on nutritional 
and molecular biomarkers, which allow mechanisms of action and biological 
effects involved in the development of CVDs to be determined.  
The following specific objectives have been set: 
Objective 1: To assess the relations between urinary total polyphenol 
excretion (TPE), a biomarker of total polyphenol intake (TPI), polyphenol-rich 
foods, and oxidative stress biomarkers in healthy adults of different ages 
following a Mediterranean dietary pattern (Clinical Study 1). 
Objective 2: To assess the modifications of plasma metabolite profiles after 
a healthy Nordic dietary intervention with whole grains, bilberries and fatty 
fish by applying a non-targeted metabolite profiling approach in subjects with 
metabolic syndrome. Furthermore, we aimed to identify novel nutritional 
biomarkers more specific than TPE, and to determine molecular biomarkers 
of endogenous metabolism modified by dietary bioactive compounds 
(Clinical Study 2). 
Objective 3: To assess the impact of a dietary intervention supplemented 
with a virgin olive oil (VOO) or two different functional VOOs enriched with 
their own phenolic compounds (PC; hydroxytyrosol derivatives) or 
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complemented with thyme PC (flavonoids, monoterpens, and phenolic acids) 
on the HDL protein cargo and on its cardiovascular profile, by applying a 
quantitative proteomics approach in hypercholesterolemic subjects from the 
Mediterranean area (Clinical Study 3). 
MATERIALS AND METHODS 
Clinical Study 1: 
A cross-sectional study in which 81 participants were classified into three 
age groups: 18 to 39, 40 to 54, and 55 to 72 years of age. The TPE was 
determined in urine samples using the Folin-Ciocalteau method. The TPI 
was quantified from 3-day dietary records using the Phenol-Explorer 
database. The extent of oxidative injury and the antioxidant capacities of 
plasma and enzymatic antioxidants were analyzed by immunoenzymatic, 
fluorometric and spectrophotometric techniques.  
Clinical Study 2: 
A randomized, controlled, parallel, dietary trial in which 106 participants were 
randomized into the following three 12- week diet interventions: (1) whole 
grain products, fatty fish and bilberries (healthy diet; HD); (2) whole grain 
enriched diet (WGED), with the same grain products as in the HD 
intervention, but with no changes in fish or berry consumption; and (3) 
refined wheat breads and restrictions on fish and berries (Control). A non-
targeted LC-MS metabolite profiling analysis was performed on fasting 
plasma samples. Additionally, correlation analyses were performed between 
the nutritional biomarker candidates and the food intake data for identifying 
the causative food items.  
Clinical Study 3: 
A randomized, double blind, cross-over, controlled trial in which 33 
hypercholesterolemic subjects were recruited. Participants were randomized 
to one of 3 sequences of administration of 25 mL/day of raw: (1) VOO, 80 
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ppm of phenolic content; (2) functional VOO enriched with its own PC, 500 
ppm of phenolic content; and (3) functional VOO enriched with its own PC 
plus complementary phenols from thyme, 500 ppm of phenolic content (50% 
olive oil phenolic compounds and 50% thyme phenolic compounds). HDL 
fractions were obtained from plasma by sequential density ultracentrifugation 
in two steps using sodium bromide. A quantitative proteomic approach, 
based on iTRAQ-OFFGEL-LC-MS/MS analysis was performed to identify 
changes in the HDL proteome after the dietary interventions. Ingenuity 
Pathway Analysis (IPA) was used to analyze canonical pathways and 
protein networks that involve the differentially expressed proteins to 
approach the biological interpretation.  
RESULTS 
Clinical Study 1: 
Urinary TPE increased with age (p < 0.001) and was inversely associated 
with urinary 8-hydroxydeoxyguanosine (8-OHdG; p < 0.001) and erythrocyte-
oxidized glutathione concentrations (p < 0.05). A negative association 
between urinary 8-OHdG and the daily intake of polyphenols from 
vegetables and from fermented beverages, such as red wine, was observed 
(p < 0.01; p < 0.05, respectively). 
Clinical Study 2: 
Marked differences in fasting plasma metabolite profiles were observed after 
the intervention diets compared with the Control diet. In both intervention 
groups a significant increase was observed in signals identified as 
glucuronidated alk(en)ylresorcinols which correlated strongly with the intake 
of whole grain products. Additionally, HD intervention increased the signals 
for the furan fatty acid 3-carboxyl-4-methyl-5-propyl-2-furanopropionic acid 
(CMPF), hippuric acid and various lipid species incorporating 
polyunsaturated fatty acids (PUFAs). Plasma hippuric acid and CMPF 
correlated with intakes of bilberries and fish, respectively. WGED 
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intervention tended to increase endogenous betaine metabolites and certain 
amino acids.  
Clinical Study 3: 
In total, 127 HDL-associated proteins were identified. Among these proteins, 
15 were commonly differentially expressed after the consumption of the 
three VOOs, although specific changes were observed for each intervention. 
The overlapping proteins among interventions were related with 
cardioprotective biological functions, and IPA signaling pathways revealed 
that these proteins were involved in a variety of canonical pathways, 
including LXR/RXR activation, acute phase response signaling, 
atherosclerosis signaling, interleukin 12 (IL-12) signaling and production in 
macrophages, production of Nitric oxide and reactive oxygen species in 
macrophages, clathrin-mediated endocytosis signaling and coagulation 
system. 
CONCLUSIONS 
1. Urinary TPE increased with age due to an increase in the 
consumption of vegetables, fruits, and coffee, and to a moderate 
intake of fermented beverages. Moreover, a higher urinary TPE is 
associated with a decrease in oxidative stress biomarkers, which may 
reflect an attenuation of oxidative damage in healthy individuals.  
2. The beneficial effects of a dietary intake rich in vegetables and 
moderate red wine on healthy individuals, could potentially be 
explained by the attenuation of oxidative damage associated with 
these typical food items of the Mediterranean diet, which are rich in 
polyphenols. 
3. A non-targeted metabolite approach based on LC-MS is an efficient 
technique in the discovery of specific novel nutritional biomarkers and 
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in reporting metabolic alterations in fasting plasma after dietary 
interventions. 
4. Fasting plasma CMPF, glucuronidated alk(en)ylresorcinols and 
hippuric acid are suggested as novel candidate biomarkers of fatty 
fish, whole grain and bilberry consumption, respectively, because 
these candidates present a strong positive correlation with the 
proposed consumed foods. 
5. Alterations in molecular biomarkers of endogenous metabolism, such 
as PUFA-containing lipids, amino acids and betaine metabolites, 
could explain the effect of whole grains, fatty fish and bilberry 
consumption on metabolic pathways, thus indicating the potential 
beneficial effects of a healthy Nordic diet. 
6. A quantitative proteomics approach based on iTRAQ-LC-MS/MS 
potentially can better elucidate the effects of dietary interventions with 
olive oils rich in PC on the complex structure of the HDL protein cargo. 
7. The consumption of VOO or phenol-enriched VOOs has an impact on 
the HDL proteome in a cardioprotective mode that could enhance 
HDL functionality by up-regulating proteins related to cholesterol 
homeostasis, protection against oxidation and blood coagulation while 
down-regulating proteins involved in acute-phase response, lipid 
transport, and immune responses.  
8. The common protein expression modifications reported after the 
consumption of the three VOOs indicate a major effect of the fatty acid 
and PC composition present in the common matrix of these VOOs on 
HDL remodeling. 
OVERALL CONCLUSION 
The use of nutritional biomarkers is a useful tool in assessing the 
mechanisms of action and the biological effects of dietary bioactive 
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compounds on CVD development. Thus, the use of omic sciences, such as 
metabolomics and proteomics, add relevant information to the discovery of 
novel nutritional and molecular biomarkers, which assist us in evaluating 
food bioactivity and food effects on human health and on disease 
prevention. 
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8-OHdG - 8-hydroxydeoxyguanosine 
A2M - Alpha-2-macroglobulin 
ACN - Acetonitrile 
AHSG - Alpha-2-HS-glycoprotein 
ANOVA - Analysis of Covariance 
ANPEP - Aminopeptidase N 
APO - Apolipoprotein 
APOA1 - Apolipoprotein A-I 
APOA2 - Apolipoprotein A-II 
APOA4 - Apolipoprotein A-IV 
APOC1 - Apolipoprotein C-I 
APOC2 - Apolipoprotein C-II 
APOC3 - Apolipoprotein C-III 
APOD - Apolipoprotein D 
APOF - Apolipoprotein F 
APOL1 - Apolipoprotein L1 
APOL2 - Apolipoprotein L2 
APOM - Apolipoprotein M 
AR - Alk(en)ylresorcinol 
AZGP1 - Zinc-alpha-2-glycoprotein 
CAT - Catalase 
CE - Capillary electrophoresis  
CETP - Cholesteryl ester transfer protein 
CHCA - α-cyano-4-hydroxycinnamic acid 
CLU - Clusterin 
CMPF - 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid 
CNDP1 - Beta-Ala-His dipeptidase 
CVD - Cardiovascular disease 
DASH - Dietary Approaches to Stop Hypertension 
DHA - Docosahexaenoic acid 
DNA - Deoxyribonucleic acid 
DTT - Dithiothreitol 
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EDTA - Ethylenediaminetetraacetic acid 
EFSA - European Food Safety Authority 
EPA - Eicosapentanoic acid 
ESI - Electrospray ionization 
FA - Formic acid 
FDR - False discovery rate 
FGA - Fibrinogen alpha chain 
FGG - Fibrinogen gamma chain 
FRAP - Ferric-reducing ability of plasma 
FTMS - Fourier transform mass spectrometry 
FVOO - Functional virgin olive oil 
GAE - Gallic acid equivalent 
GC - Gas chromatography  
GC - Vitamin D-binding protein 
GPx - Glutathione peroxidase 
GSH - Reduced glutathione 
GSSG - Oxidized glutathione 
HD - Healthy diet 
HDL - High-density lipoprotein 
HILIC - Hydrophilic interaction 
HP - Haptoglobin 
HRG - Histidine-rich glycoprotein 
hsCRP - High-sensitivity C-reactive protein 
ICAM -1 - Intercellular adhesion molecule-1 
IDL - Intermediate-density lipoprotein 
IL-12 - Interleukin 12 
IL-1β - Interleukine-1β 
IL-6 - Interleukin 6 
IPA - Ingenuity pathway analysis 
IPG - Immobilized pH gradient 
ITIH1 - Inter-alpha-trypsin inhibitor heavy chain H1 
ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4 
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iTRAQ - Isobaric tagging for relative and absolute quantification  
KNG1 - Kininogen-1 
LC – Liquid chromatography  
LCAT - Phosphatidylcholine-sterol acyltransferase 
LDL - Low-density lipoprotein 
LPA - Apolipoprotein(a) 
LPC - Lysophosphatidylcholines 
LPE - Lysophosphatidyl-ethanolamines 
LXR/RXR - Liver X receptor/retinoid X receptor 
MALDI - Matrix-assisted laser desorption/ionization 
MD - Mediterranean diet 
MetS - Metabolic syndrome 
MS - Mass spectrometry 
MUFA - Monounsaturated fatty acids 
MW - Molecular weight 
NMR - Nuclear magnetic resonance 
NO - Nitric oxide 
NR5A2 - Nuclear receptor subfamily 5, group A, member 2 
Nrf2 - Nuclear factor erythroid 2-related 2 
OGE - OFFGEL electrophoresis 
OO - Olive oil 
ORAC - Oxygen radical absorbance capacity 
ORM1 - Alpha-1-acid glycoprotein1 
ORM2 - Alpha-1-acid glycoprotein 2 
oxLDL - Oxidized LDL 
PAI-1 - Plasminogen activator inhibitor-1 
PC - Phenolic compounds 
PCh - Phosphatidylcholines 
PF4 - Platelet factor 4 
PIC - Protease inhibitor cocktail 
PLS-DA - Partial least squares discriminant analysis 
PON3 - Serum paraxonase/lactonase 3 
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PPBP - Platelet basic protein 
ppm - Parts per million 
PSM - Peptide-spectrum match 
PUFA - Polyunsaturated fatty acids 
QC - Quality control 
RBP4 - Retinol-binding protein 4 
RNA - Ribonucleic acid 
ROS - Reactive oxygen species 
RP - Reversed phase 
SAA1 - Serum amyloid A protein 
SAA4 - Serum amyloid A protein 4 
SCORE - Systemic Coronary Risk Evaluation 
SCX - Strong-cation exchange 
SDS - Sodium dodecyl sulfate 
SERPINA5 - Plasma serine protease inhibitor 
SERPINC1 - Antithrombin-III 
SERPIND1 - Heparin cofactor 2 
SERPINF2 - Alpha-2-antiplasmin 
SMC - Smooth muscle cell 
SOD - Superoxide dismutase 
SPSS - Statistical package for the social sciences 
TBARS - Thiobarbituric acid reactive substances 
TCA - Tricloroacetic acid 
TCEP - Tris-(2-carboxyethyl)phosphine 
TFA - Trifluoroacetic acid 
TMT - Tandem mass tags 
TNF-α - Tumor necrosis factor-α 
TOF - Time of flight 
TPE - Total polyphenol excretion 
TPI - Total polyphenol intake 
UHPLC - Ultra high performance liquid cromatography 
UNESCO - United Nations Educational, Scientific and Cultural Organization 
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VCAM-1 - Vascullar cell adhesion molecule-1 
VIP - Variable influence on projection 
VLDL - Very-low-density lipoprotein 
VOO - Virgin olive oil 
WGED - Whole grain enriched diet 
WHO - World Health Organization 
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CHAPTER 1: CARDIOVASCULAR DISEASE 
1.1 DEFINITION AND EPIDEMIOLOGY 
Cardiovascular diseases (CVDs) are a group of disorders of the heart and 
blood vessels, including coronary heart disease, cerebrovascular disease 
and peripheral arterial disease. The World Health Organization (WHO, 2013) 
identifies CVDs as the leading cause of death worldwide and estimates that 
17.3 million people died from CVDs in 2008, representing 30% of all global 
deaths. Of these deaths, an estimated 7.3 million were due to coronary heart 
disease, and 6.2 million were due to stroke. The number of people who die 
from CVDs, primarily from heart disease and from stroke, is predicted to 
increase and to reach 23.3 million by 2030. CVDs were once considered 
diseases that occur more frequently in industrialized countries. However, in 
recent years, there has been an increase in CVD risk factors globally, 
including obesity, hypertension and diabetes, reflecting significant global 
changes in behavior and lifestyle. The WHO states that over 80% of CVD 
deaths currently occur in low and middle income countries and almost 
equally in men and women. Atherosclerosis is the major biological process 
that causes both ischemic stroke and myocardial infarction and, thus, is the 
principal cause of cardiovascular death. Cardiovascular primary prevention, 
including identifying and treating at-risk individuals, remains a major public 
health priority. 
1.2 PATHOPHYSIOLOGY OF ATHEROSCLEROSIS  
Understanding the pathophysiology of atherosclerosis progression has been 
a major objective of CVD research in recent decades. This understanding is 
essential for improving strategies for CVD prevention and for developing 
new and effective treatments. Oxidative stress, inflammation, endothelial 
dysfunction and thrombosis are key mechanisms involved in the onset and 
progression of atherosclerosis. 
The initiation of atherosclerosis is due to a qualitative change in the 
monolayer of endothelial cells that line the inner arterial surface. Endothelial 
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cells express adhesion molecules that capture leukocytes (monocytes and T 
lymphocytes) on their surfaces when subjected to pro-inflammatory 
mediators (Figure 1B; Libby et al., 2011). Vascular cell adhesion molecule-1 
(VCAM-1) is one of the most important adhesion molecules in this interaction 
between the endothelium and leukocytes; however, other adhesion 
molecules, such as E-selectin, P-selectin and intercellular adhesion 
molecule-1 (ICAM-1) are also expressed in endothelial cells (Gui et al., 
2012; Libby, 2012). In parallel, changes in endothelial permeability and the 
composition of the extracellular matrix stimulate the entrance and retention 
of low-density lipoprotein (LDL) particles in the artery wall. Then, LDL 
particles are oxidized into pro-inflammatory particles (oxidized LDL; oxLDL), 
which incite an inflammatory reaction within the intima, and consequently, 
several cytokines, such as interleukin-1β (IL-1β) and tumor necrosis factor-α 
(TNF-α), are released, causing the expression of adhesion molecules in 
endothelial cells and, consequently, the binding of leukocytes to the arterial 
wall (Libby, 2006).  
Once monocytes adhere to the arterial endothelium, these cells penetrate 
the endothelial lining and enter the intima of the vessel wall; this process 
requires chemoattractant mediators. Within the intima, monocytes 
differentiate into tissue macrophages. In the nascent atheroma, 
macrophages express scavenger receptors that permit the uptake of oxLDL 
and become foam cells that develop fatty streaks (Gui et al., 2012; Insull, 
2009). Simultaneously, macrophages multiply and release several growth 
factors and cytokines, thus amplifying and sustaining pro-inflammatory 
signals and promoting thrombotic complications (Gui et al., 2012). T 
lymphocytes and mast cells also accumulate in atheroma plaques (Figure 
1B). These early changes are microscopic and may progress to major 
visibility; additionally, these lipid changes can be reversed (Insull, 2009; 
Libby et al., 2011). 
During the progression of a complex atheromatous plaque, smooth 
muscle cells (SMCs) are recruited from the tunica media into the tunica 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Introduction 
9 
intima and proliferate in response to mediators such as platelet-derived 
growth factor. In the intima, the SMCs produce extracellular matrix 
molecules, including collagen and elastin, and form a fibrous cap that covers 
the plaque, which is a collection of foam cells and released lipids that 
accumulate in extracellular regions (Libby et al., 2011). During this process, 
calcium deposition is produced in atheromatous plaques, initially as small 
aggregates and later as large nodules (Figure 1C; Insull, 2009). 
Plaques generally cause clinical manifestations by producing flow-limiting 
stenosis that leads to tissue ischemia or by inciting thrombosis that can 
interrupt blood flow locally or in distal arteries. Thrombotic complications 
often appear after physical disruption of the plaque and, most commonly, 
after a fracture of the fibrous cap. Plaques that rupture typically have thin, 
collagen-poor fibrous covers with few SMCs but abundant macrophages 
(Libby et al., 2011). The inflammatory cells (T lymphocytes) may accelerate 
plaque disruption by producing collagenolytic enzymes that can degrade 
collagen and by generating mediators that provoke the death of SMCs, 
which are the source of arterial collagen (Libby, 2013). Macrophages that 
are in plaques also produce tissue factor, which is a procoagulant that 
promotes the thrombogenicity of the lipid core (Gui et al., 2012). When a 
plaque ruptures, a thrombus forms that is responsible for most of the acute 
complications of atherosclerosis (Figure 1D; Libby, 2006)  
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Figure 1. Development of atherosclerotic lesions. A) A normal artery contains three layers. 
The inner layer, or tunica intima, is lined by a monolayer of endothelial cells that is in contact 
with blood overlying a basement membrane. The middle layer, or tunica media, contains SMCs 
embedded in a complex extracellular matrix. The adventitia, which is the outer layer of arteries, 
contains mast cells, nerve endings and microvessels. B) The initial steps of atherosclerosis 
include adhesion of blood leukocytes to the activated endothelial monolayer, directed migration 
of the bound leukocytes into the intima, maturation of monocytes into macrophages, and lipid 
uptake by these machrophages, yielding foam cells. C) Lesion progression involves the 
migration of SMCs from the media to the intima, the proliferation of resident intimal SMCs and 
media-derived SMCs, and the heightened synthesis of extracellular matrix macromolecules, 
such as collagen, elastin and proteoglycans. Plaque macrophages and SMCs can die, some by 
apoptosis, in advancing lesions. Extracellular lipids derived from dead and dying cells can 
accumulate in the central region of a plaque, often called the lipid or necrotic core. Advancing 
plaques also contain cholesterol crystals and microvessels. D) Thrombosis, which is the 
ultimate complication of atherosclerosis. A fracture of the plaque’s fibrous cap is shown, which 
has enabled blood coagulation components to access tissue factors in the plaque’s interior, 
triggering thrombus that extends into the vessel lumen, where blood flow can be impede. 
Source: (Libby et al., 2011). 
Oxidative stress plays an important role in the development of this thesis. 
Therefore, the specific function of oxidative stress in the atherosclerotic 
process is explained in greater detail below. 
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Oxidative stress is a potent inductor of endothelial dysfunction and is 
involved at all stages of atherosclerotic plaque evolution (Schnabel et al., 
2007). Oxidative stress culminates due to an imbalance between pro-
oxidants and antioxidants and a consequent excessive production of 
reactive oxygen species (ROS), contributing to the oxidative damage of 
lipids in cellular membranes, as well as in proteins and in deoxyribonucleic 
acid (DNA). Endogenous antioxidant enzymes and exogenous dietary 
antioxidants can prevent intracellular ROS concentrations from reaching 
levels at which damage occurs (Li et al., 2013). Risk factors for 
cardiovascular disease, such as hypertension, hypercholesterolemia, 
diabetes mellitus, and tobacco use, as well as CVD itself, are all associated 
with significant increases in ROS in the vascular wall, a situation that 
eventually culminates with oxidative stress. During atherosclerosis 
progression, ROS are produced by endothelial cells, SMCs and 
macrophages (Figure 2). Under oxidative stress, the enzymatic production 
of ROS exceeds the available antioxidant defense systems (Li et al., 2013). 
ROS overproduction under pathophysiological conditions is integral to the 
development of CVDs. ROS mediate various signaling pathways that cause 
vascular inflammation in atherogenesis: from the initiation of fatty streak 
development, through lesion progress, to ultimate thrombotic activity and 
plaque rupture. ROS reduce the production of nitric oxide (NO), which is an 
endothelium relaxant factor that modulates endothelial tone and reactivity. 
The reduced bioavailability of vascular NO is the most important mechanism 
of endothelial dysfunction observed in CVDs (Li et al., 2013). In addition, 
vascular oxidative stress promotes atherogenesis through numerous 
different mechanisms, including the activation of redox-sensitive 
transcription factors (which stimulate the expression of proinflammatory 
genes) and the induction of lipid peroxidation, protein oxidation, and 
mitochondrial and nuclear DNA damage (Li et al., 2013). 
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Figure 2. Pathophysiology of atherosclerosis. ROS produced by endothelial cells, SMCs, 
and macrophages oxidize LDLs in the subendothelial space, at the sites of endothelial damage, 
initiating events that culminate in the formation of a fibrous plaque. Fibrous plaque rupture leads 
to thrombus formation and vascular occlusion. Source: (Madamanchi et al., 2005). 
1.3 CARDIOVASCULAR DISEASE RISK FACTORS 
CVD prevention can improve the well-being of a population and possibly 
decrease healthcare spending. Therefore, CVD prevention should be the 
most important aspect of any sustainable health economy model. In recent 
decades, prevention strategies have contributed to a 50% decrease in CVD 
mortality observed in many high income countries (Perk et al., 2012). 
CVD risk denotes the likelihood of a person developing a cardiovascular 
event over a defined period. CVD risk factors have emerged from a 
combination of epidemiological studies performed worldwide and are the 
elements that affect the probability and the risk of developing CVDs. The 
concepts of CVD risk factors and risk estimation have become integral parts 
of modern medical programs and have led to the development of effective 
treatments and preventive strategies in clinical practice (Framingham Heart 
Study, 2014).  
CVD risk factors can be classified into two categories: non-modifiable risk 
factors and modifiable risk factors. The non-modifiable risk factors include 
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genetic factors, age and gender. There is evidence of strong heritability of 
many cardiovascular risk factors and of atherosclerotic disease (Perk et al., 
2012). Increasing age and the male gender increase CVD risk and are 
stable characteristics used to stratify risk assessments. In contrast, CVDs 
are strongly connected to modifiable lifestyle risk factors, particularly the use 
of tobacco, unhealthy dietary habits, physical inactivity and psychosocial 
stress. The WHO has stated that 80% of CVD cases may be avoided with 
lifestyle changes. These unhealthy behaviours may cause an increase in the 
major intermediate biological risk factors that lead to CVDs, including blood 
pressure, blood glucose, blood lipids, overweight and obesity. These 
intermediate biological risk factors are considered the traditional or classical 
risk factors (Perk et al., 2012).  
First, we focus our interest on classical risk factors for CVDs; however, 
emerging risk factors are also explained.  
1.3.1 Classical risk factors 
Traditional or classical risk factors are normally measured in primary care 
and are important risk assessment tools that have led to the development of 
predictive models of cardiovascular risk estimation, such as the Framingham 
10-year risk score or the European Systematic Coronary Risk Evaluation 
(SCORE) (Artigao-Rodenas et al., 2013; Jørstad et al., 2013). The 
involvement of these classic risk factors in CVDs will be briefly explained: 
- Elevated blood pressure: In several epidemiological studies, 
elevated blood pressure (BP) has been identified as a major risk 
factor for CVDs (Perk et al., 2012). Even small increases in BP are 
associated with an increased risk of cardiovascular events. BP is a 
heritable trait influenced by multiple biological pathways and 
responds to environmental stimuli, such as diet, use of tobacco and 
stress (Ehret et al., 2011; Lewington et al., 2002). 
- Elevated glucose blood levels: Existing data indicate a relation 
between increased levels of glycaemia and cardiovascular events. 
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The risk of cardiovascular events or death increases progressively 
among individuals who are normoglycaemic, with impaired fasting 
glucose or impaired glucose tolerance, and newly diagnosed 
diabetics (Anand et al., 2012). A 1 mmol/L increase in the fasting 
plasma glucose level is associated with a 17% increase in the risk of 
future cardiovascular events or death. The intensive management of 
hyperglycaemia in diabetes reduces the risk of micro-vascular 
complications and, to a lesser extent, the risk of CVDs (Ton et al., 
2013). 
- Elevated lipid blood levels: Increased plasma cholesterol and LDL 
cholesterol levels are among the major risk factors for CVDs (Perk et 
al., 2012). Hypertriglyceridemia and low high-density lipoprotein 
(HDL) cholesterol concentrations are independent CVD risk factors. 
Because low concentrations of HDL cholesterol are independently 
associated with higher CVD risk, this parameter is also included in 
new SCORE charts (Chapman et al., 2011). 
A specific topic for this thesis is the cardioprotective effect of the 
HDL particle. Thus, this lipoprotein is explained in greater detail 
below. 
HDL particle 
In epidemiological studies, low plasma HDL cholesterol levels have 
shown an inverse relation to the CVD risk. HDL particles play a 
central role in the efflux of cholesterol from peripheral tissues, which 
may be vital to the atheroprotective effects of HDL (Annema et al., 
2013).  Therefore, the HDL particle is being intensely investigated as 
a potential therapeutic target in patients at high cardiovascular risk. 
However, several recent pharmacological and genetic studies have 
failed to demonstrate that increased HDL cholesterol plasma levels 
result in decreased CVD risk, creating controversy regarding 
whether HDL cholesterol plasma levels reflect HDL function. It is 
important to distinguish between HDL function and HDL cholesterol 
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plasma levels (Lüscher et al., 2014).  In fact, it has been argued that 
low HDL cholesterol may only represent a marker for proatherogenic 
risk factors, rather than HDL being a mediator that protects against 
atherogenesis (Lüscher et al., 2014). Currently, a greater 
understanding of the complexity of HDL composition and biology has 
driven researchers to redefine the HDL particle. Thus, the focus of 
HDL has now begun to change from a cholesterol-centric view 
toward HDL particle number, subclasses and HDL composition. 
Many of the recently discovered functions of HDL are, actually not 
strictly conferred by its ability to promote cholesterol efflux but by the 
other molecules HDL transports, including a diverse set of proteins, 
small ribonucleic acids (RNAs), hormones, carotenoids, vitamins, 
and bioactive lipids (Vickers et al., 2014). Novel biological and 
atheroprotective activities are specifically related to HDL protein 
cargo. Currently, studying the HDL proteome has become important 
in the entire study of HDL functionality, and approximately one 
hundred different proteins, except for apolipoproteins (APOs), have 
been associated with the HDL particle (Shah et al., 2013). These 
new HDL-associated proteins have been linked with the following 
cardioprotective activities of the HDL particle: antioxidative, anti-
inflammatory, antithrombotic, complement system regulation and 
protective effects on vascular endothelium and SMCs (Vickers et al., 
2014; Figure 3).  
For the above mentioned, it is important to demonstrate that novel 
therapeutic interventions not only increase HDL cholesterol plasma 
levels but also improve HDL functionality in patients at high 
cardiovascular risk, principally remodeling the HDL proteome 
(Lüscher et al., 2014). 
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Figure 3. Proposed direct vascular protective and potentially antiatherogenic effects of 
HDL. HDL from healthy subjects stimulates NO release from human aorta endothelial cells and 
increases the expression of endothelial nitric oxide synthase. Furthermore, HDL suppresses the 
expression of adhesion molecules, such as VCAM-1, and inhibits the adhesion of white blood 
cells. HDL also exerts antithrombotic effects because this lipoprotein reduces tissue factor 
expression in endothelial cells exposed to cytokines and reduces platelet activation. Source: 
(Lüscher et al., 2014). 
- Overweight and obesity: Obesity has become a major global 
contributor to CVD incidence and mortality. The visceral adipose 
tissue is a metabolically active endocrine organ capable of 
synthesizing and releasing an important variety compounds that may 
play a role in cardiovascular homeostasis into the bloodstream. This 
process affects CVD risk factors and hence on CVD risk (Perk et al., 
2012). Overweight and obese individuals more commonly have 
other CVD risk factors, such as diabetes, insulin resistance, 
dyslipidemia and hypertension.  This metabolic network is known as 
metabolic syndrome (MetS), which is a complex disorder that 
directly increases the CVD risk. MetS causes a high socioeconomic 
cost and is considered a worldwide epidemic (Kassi et al., 2011; 
Samson et al., 2014).  
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1.3.2 Emerging risk factors 
Classical risk factors do not fully explain the inter-individual variation in 
cardiovascular risk. Intensive studies during the past decade have led to a 
deeper understanding of the biology and pathophysiology of atherosclerosis, 
which has provided new emerging risk factors (Ge et al., 2012). Oxidative 
stress, inflammation, endothelial dysfunction and thrombosis are processes 
that are involved in the pathogenesis of atherosclerosis and that have 
emerged as new risk factors for cardiovascular events before symptoms 
appear. Several studies have evaluated a series of candidate biomarkers of 
inflammation, oxidative stress, endothelial dysfunction and thrombosis as 
potential clinical tools for improving atherosclerosis prediction (Gui et al., 
2012). Emerging validated biomarkers may add value in the context of 
specialized practice, for assessing CVD risk more precisely in specific 
subgroups of patients at moderate, unusual, or undefined levels of risk (Perk 
et al., 2012). Thus far, no biomarker has emerged as the best screening 
marker of CVD risk, and no single biomarker is sufficiently sensitive or 
specific for use on its own; instead, larger biomarker panels are used 
(Gilstrap et al., 2012). In Chapter 3, emerging CVD biomarkers will be 
explained in greater detail.  
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CHAPTER 2: DIET AND CARDIOVASCULAR DISEASE 
Dietary habits are known to influence CVD risk, either through an effect on 
intermediate biological risk factors such as serum cholesterol, blood 
pressure, body weight, and diabetes, or through an effect independent of 
these risk factors. Currently, numerous epidemiological studies have shown 
several important links between diet and CVD occurrence (Engelfriet et al., 
2010). A healthy dietary pattern can delay the development of 
atherosclerosis, thus reducing the incidence of coronary events, and is an 
important modifiable risk factor in CVD prevention (Perk et al., 2012). 
According to the European Guidelines on CVD prevention in clinical practice, 
the recommended characteristics of a healthy dietary pattern are described 
in Table 1. 
Table 1. Characteristics of a healthy dietary pattern. 
FOODS OR 
NUTRIENTS 
HEALTHY DIETARY PATTERN RECOMMENDED 
Saturated fatty 
acids 
to account for < 10% of total energy intake, through replacement by polyunsaturated 
fatty acids 
Trans-unsaturated 
fatty acids 
to account for < 1% of total energy intake from natural origin, with preferably no intake 
from processed food 
Salt < 5 g per day 
Fiber 30 - 45 g per day, from whole grain products, legumes, fruits and vegetables 
Fruits 200 g per day (2 -3  servings per day) 
Fish at least twice a week, one of which should be fatty fish 
Alcoholic 
beverages 
should be limited to two glasses per day (20 g/ day of alcohol) for men and to one 
glass per day (10 g/ day of alcohol) for women 
Source: (adapted from Perk et al., 2012). 
The effect of diet on CVD risk can be studied at different levels, with the 
study of specific bioactive compounds as the most detailed method. 
Examining food groups is another method of assessing diet, and is more 
easily translated into dietary recommendations. Finally, there is growing 
interest in studying the effect of dietary patterns on CVD risk, and currently, 
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the Mediterranean diet (MD) is the most studied dietary pattern (Perk et al., 
2012).  
2.1 BIOACTIVE COMPOUNDS 
In this section, we define and summarize the effects of some of the most 
important bioactive compounds that influence CVD risk. Moreover, we 
introduce a special section to discuss phenolic compounds (PC) because 
these compounds are bioactive molecules that have played a central role in 
the development of this thesis.  
Bioactive compounds are defined as essential and non-essential compounds 
that occur in nature. These compounds are part of the food chain, and can 
provide human health benefits beyond the basic nutritional value of the food 
(Biesalski et al., 2009). A wide variety of foods offer a range of different 
bioactive compounds, including vitamins, minerals, fiber and phytochemicals 
(Liu, 2013). Increasing evidence suggests that CVD health benefits of plant 
foods are attributed to the additive and synergistic interactions of the 
bioactive compounds present in these foods by targeting multiple signal 
transduction pathways (Liu, 2013). 
The effects of sodium and potassium intake on blood pressure are well 
established. The Dietary Approaches to Stop Hypertension (DASH) trial 
(Kwan et al., 2013) showed an inverse dose-response relation between 
sodium intake and blood pressure. In contrast, a higher potassium intake 
has been shown to reduce this classical risk factor. Moreover, a diet rich in 
magnesium and calcium has been related to favorable effects on blood 
pressure (Kwan et al., 2013). 
Many case-control and prospective observational studies have observed 
inverse associations between levels of different vitamins, such as vitamin A, 
vitamin E, vitamin B6, vitamin B12, folic acid and vitamin D, and CVD risk 
(Perk et al., 2012). Consistent with these studies, in vitro studies performed 
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by our group showed that alpha-tocopherol, which is a form of vitamin E, 
prevents endothelial dysfunction (Catalán et al., 2012). 
It is well established that the consumption of dietary fiber reduces CVD risk 
(Perk et al., 2012). One of the mechanisms involved in its effect is its 
capabilities of reducing the post-prandial glucose response after 
carbohydrate-rich meals and of lowering total and LDL cholesterol levels in 
the blood. Important sources of fiber include whole grain products, legumes, 
fruits and vegetables (Threapleton et al., 2013). 
Phytochemicals are defined as bioactive non-nutrient plant chemicals 
present in fruits, vegetables, grains, legumes, nuts and other plant foods that 
may provide desirable health benefits beyond basic nutrition to reduce the 
risk of major chronic diseases, such as CVDs (Liu, 2004). Dietary 
phytochemicals can be classified into broad categories, such as PC, 
alkaloids, nitrogen-containing compounds, organosulfur compounds, 
phytosterols, and carotenoids (Liu, 2004). Of these phytochemical groups, 
PC are the most important and most studied in relation to CVDs. 
2.1.1 Phenolic compounds  
Several thousand molecules with polyphenol structures have been identified 
in higher plants, and several hundred have been found in edible plants. PC, 
which are also called polyphenols, are secondary metabolites of plants and 
are generally involved in the defense against ultraviolet radiation or 
aggression by pathogens. PC represent the most abundant antioxidants in 
human diets (Manach et al., 2004). An aromatic ring carrying one or more 
hydroxyl moieties is present in their structure, and different classes of PC 
can be considered according to the number of phenol rings and to the 
structural elements that bind these rings (Andrés-Lacueva et al., 2009). 
In this context, PC have been classified into two primary groups:  
- Flavonoids: these compounds are composed of all PC with a C6-C3-C6 
structure (Figure 4). In this group we find the following subgroups: 
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flavanones, dihydroflavonols, flavan-3-ols, isoflavones, flavones, flavonols, 
anthocyanidins and proanthocyanidins (Andrés-Lacueva et al., 2009; 
Manach et al., 2004). 
 
Figure 4. C6-C3-C6 structure from which all flavonoid compounds are derived. 
- Non-flavonoids: these compounds are classified according to their 
number of carbons and include the following subgroups: simple phenols, 
benzoic acids, hydrolysable tannins, acetophenones and phenylacetic acids, 
cinnamic acids, coumarins, benzophenones, xanthones, stilbenes, 
chalcones, lignans and secoiridoids (Andrés-Lacueva et al., 2009; Manach 
et al., 2004). 
 
Figure 5. Chemical structures of some of non-flavonoids compounds. Source: (Manach et 
al., 2004). 
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Occurrence of phenolic compounds in foods  
Flavonoid and non-flavonoid compounds are present in significant amounts 
in many commonly consumed fruits, vegetables, grains, beverages and 
herbs. Table 2 summarizes the PC classification (primary groups and 
subgroups), and provides examples of the primary dietary sources for each 
subgroup. 
Table 2. Flavonoid and non-flavonoid compounds in foods.  
 
SUBGROUPS 
PHENOLIC COMPOUNDS 
EXAMPLES 
PRIMARY DIETARY 
SOURCES 
FLAVONOIDS 
Flavonols quercitin and kaempferol 
vegetables and some 
species, such as capers, 
onions, asparagus, berries 
and lettuce 
Flavones 
apigenin and luteolin 
glycosides 
species such as parsley and 
thyme 
Flavanones hesperetin and naringenin citric fruits 
Isoflavones genistein and daidzein 
almost exclusively in 
leguminous plants 
Anthocyanidins 
cyanidin, delphinidin, 
malvidin, peonidin, and 
petunidin 
berries and other red-blue 
fruits and vegetables 
Flavan-3-ols catechin and epicatechin 
Tea, chocolate, many types 
of fruit, red wine, beer and 
nuts 
Proanthocyanidins procyanidins 
cinnamon, sorghum, beans, 
red wine and chocolate 
NON-
FLAVONOIDS 
Simple phenols hydroxytyrosol and tyrosol virgin olive oil 
Benzoic acids ellagic and gallic acids berries and grapes 
Hydrolysable tannins 
ellagitannins and 
gallotannins 
berries 
Acetophenones and 
phenylacetic acids 
- fermented soya bean 
Cinnamic acids 
p-coumaric, caffeic, ferulic 
and sinapic acids 
fruits and vegetables, with 
ferulic acid the most 
abundant in cereal grains 
Coumarins scopoletin 
fruits, green tea and other 
foods, such as chicory 
Benzophenones - distributed scarcely in foods 
Xanthones - mangosteen 
Stilbenes resveratrol 
red wine, grape and grape 
products 
Chalcones chalconaringenin 
apple juice, cider and 
pomace 
Lignans pinoresinol wine, beer, tea and coffee 
Secoiridoids oleuropein olive fruits 
Source: (adapted from Andrés-Lacueva et al., 2009; Manach et al., 2004). 
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Bioavailability and cardiovascular health effects 
Clinical and epidemiological studies have provided evidence that phenol-rich 
foods and phenol-rich diets have protective effects against chronic diseases, 
such as CVDs. Knowledge regarding the bioavailability of phenolic 
compounds is essential for researchers to understand their biological health 
effects. The most common PC in the human diet are not necessarily the 
most active in vivo, because these compounds either have a lower intrinsic 
activity than others or are poorly absorbed from the intestine, highly 
metabolized, or rapidly eliminated (Manach et al., 2004). In foods, almost all 
PC are present in glycosylated forms; thus, these compounds cannot be 
absorbed directly in their native form. These substances must be hydrolyzed 
by intestinal enzymes or by the gut microbiota before absorption. During 
absorption, PC are conjugated in the small intestine and later in the liver, 
facilitating their biliary and urinary elimination by increasing their 
hydrophilicity. Circulating PC are conjugated derivatives that are extensively 
bound to albumin. PC that are secreted via the biliary route into the 
duodenum can be subjected to enterohepatic recycling, which may lead to a 
longer presence of PC within the body (Manach et al., 2004). 
PC that are not absorbed in the small intestine reach the colon, where gut 
microbiota hydrolyze glycosides into aglycones and extensively metabolize 
aglycones into various aromatic acids. The majority of these acids are 
further metabolized to derivatives of benzoic acid and, finally, into hippuric 
acid (Moco et al., 2012). These microbial metabolites are absorbed and 
conjugated with glycine, glucuronic acid or sulfate and may have an 
important physiological effect. Plasma polyphenol microbial metabolites are 
generally much more abundant than the native intact PC from the diet and 
are proposed to exert systemic and beneficial effects on cardiovascular 
health (van Dorsten et al., 2010). However, great inter-individual variability 
exists regarding the capacity to produce active metabolites by the gut 
microbiota and depends on the colonic microbial population composition, 
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which, in turn, can be modulated by phenol-rich foods (Cardona et al., 2013; 
Moco et al., 2012). 
Extensive literature based on in vitro and in vivo studies assess the health 
effects of certain PC subgroups, phenol-rich foods, and total PC intake on 
cardiovascular risk biomarkers. In the PREDIMED trial, a significant 
reduction of cardiovascular events and cardiovascular mortality has been 
shown with a higher total PC intake. Specifically, lignans, flavanols and 
hydroxybenzoic acids were the PC subgroups with greater involvement in 
this inverse association (Tresserra-Rimbau et al., 2014). PC have a wide 
range of biological activities beyond their direct antioxidant activity, including 
anti-allergenic, anti-inflammatory, anti-microbial, anti-thrombotic, cardio 
protective and vasodilatory effects. Various mechanisms have been 
proposed to explain their biological activity, including signal transduction 
regulation and redox-sensitive transcription factors modulation (Hollman et 
al., 2011; Stevenson et al., 2007). 
2.2 FOODS AND FOOD GROUPS 
Diets are composed of foods rather than single bioactive compounds or 
macronutrients, and thus, dietary recommendations using foods are more 
likely to be understood and adopted by the population. Therefore, specific 
foods and food groups have been studied to assess their effect on CVD risk. 
We briefly explain some of the food groups in which beneficial effects on 
CVD risk have been studied. Those foods studied during the development of 
this thesis are specifically mentioned.  
2.2.1 Fruits and vegetables 
Observational studies have shown a protective effect of fruit and vegetable 
consumption on CVD prevention. The DASH trial has shown that increasing 
fruit and vegetable intake contributes to a decrease in blood pressure (Kwan 
et al., 2013; Perk et al., 2012). The protective effects of fruits and vegetables 
are because these foods are a major source of potassium, fiber, vitamins 
and antioxidants, such as PC.  
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Berries are specific types of fruits particularly abundant in PC, of which 
anthocyanidins are the most occurrence subgroup. The PC in berries are 
responsible for the many reported health benefits of these fruits. Berries 
have been reported to lower blood glucose, to have anti-inflammatory and 
lipid-lowering effects, to promote antioxidant defense and to lower oxidative 
stress (Chu et al., 2011). 
2.2.2 Alcoholic beverages 
Results from epidemiological studies have shown a protective effect of 
moderate alcohol consumption on CVD occurrence (Perk et al., 2012). The 
alcoholic beverage most studied because of its healthy properties is red 
wine; however, the interest in the study of beer is increasing. The protective 
cardiovascular effects of these fermented beverages are primarily related to 
their non-alcoholic fraction and, above all, to their phenolic composition; 
nevertheless, their alcoholic fraction is also related to protection against 
CVD (Arranz et al., 2012; Chiva-Blanch et al., 2014). A recent study 
demonstrated that resveratrol, which is the most important PC of wine, may 
promote health by maintaining and enhancing vasculature plasticity 
(Thompson et al., 2014).  
2.2.3 Whole grain 
Epidemiological evidence suggests that whole grain consumption lowers 
CVD risk. Whole grains present numerous bioactive components with 
healthy enhancing properties, such as fiber, magnesium, inulin, β-glucan, 
resistant starch, carotenoids, tocopherols, tocotrienols, betaines, PC and 
alkylresorcinols (Fardet, 2010; Ye et al., 2012). Many protective 
physiological mechanisms may be associated with whole grain cereal 
consumption because of the high number of protective bioactive compounds 
present (Fardet, 2010). Alkylresorcinols are plant-derived phenolic lipids, 
present in high concentrations in the outer layers of wheat, rye and barley 
grains, which were reported to show healthy biological activities (Ross et al., 
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2010). Whole grains are the major dietary sources of betaine, which is a 
methyl donor that is involved in CVD protection (Fardet, 2010).  
2.2.4 Fish 
The evidence for the beneficial effects of fatty fish consumption on CVD risk 
is strong, particularly because of its n-3 polyunsaturated fatty acids content 
(PUFA; Raatz et al., 2013). Eicosapentaenoic fatty acids and 
docosahexaenoic fatty acids are representatives of the n-3 PUFA group. 
Current data provide evidence that n-3 PUFAs are bioactive fatty acids that 
reduce the risk of cardiac death by affecting molecular pathways and by 
regulating genes that are critical for controlling lipid homeostasis (Eftekhari 
et al., 2014; Mozaffarian et al., 2011). A meta-analysis showed that eating 
fish 2-4 times a week reduced the risk of stroke by 18% compared with 
eating fish less that once a month. A modest increase in fish consumption of 
1-2 servings a week has been shown to reduce CVD mortality by 36% and 
all-cause mortality by 17% (Perk et al., 2012).  
2.2.5 Olive oil 
Olive oil (OO) is one of the most characteristic features of the MD and its 
consumption has been associated with beneficial effects on human health. 
Many of the health benefits reported for olives and for OO are thought to be 
associated with their phenolic contents and particularly with their 
hydroxytyrosol levels (Charoenprasert et al., 2012). The phenolic content of 
virgin OO is influenced by the variety, location, degree of ripeness and the 
type of oil extraction procedure. Hydroxytyrosol is one of the major PC 
present in virgin OO and shows a variety of pharmacological activities, such 
as antioxidant properties; anticancer, anti-inflammatory, neuroprotective 
activities; and beneficial effects on the cardiovascular system, demonstrating 
its potential for the development of dietary supplements (Hu et al., 2014). 
Recently, the European Food Safety Authority (EFSA) released a health 
claim concerning the protective effects of the ingestion of PC from OO on 
plasma lipid levels, oxidative damage, blood pressure and inflammatory 
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state. To support this claim, the EFSA panel recommends the daily 
consumption of 5 mg of hydroxytyrosol and its derivatives in OOs (European 
Food Safety Authority, 2011). However, the phenolic concentrations in most 
commercially available virgin olive oils (VOOs) are too low to allow the 
regular consumption of these amounts of hydroxytyrosol. Therefore, the 
enrichment of VOO with its own PC could be a possible strategy to increase 
and to standardize the daily intake of hydroxytyrosol without increasing the 
caloric intake (Rubió et al., 2012; Suárez et al., 2011). Moreover, the 
enrichment of VOOs with PC of aromatic herbs, such as thyme, is also used 
for improving the nutritional profile and sensorial characteristics of VOO 
( ubi  et al., 2012). 
In addition, other health claims not related to OO PC are currently possible 
for OO, such as monounsaturated fatty acids (MUFAs) and vitamin E. 
MUFAs replace saturated fats in the diet and contribute to the maintenance 
of normal blood cholesterol levels. Elsewhere, vitamin E contributes to 
cellular protection against oxidative stress (Martín-Peláez et al., 2013).  
2.2.6 Legumes and Nuts 
Legumes and nuts are foods present in the MD that are rich in several 
bioactive compounds. Legumes are rich in lecithin, phytoestrogens, 
oligosaccharides and PC, which play cardiometabolic roles in humans 
(Bouchenak et al., 2013). There is convincing evidence that increasing the 
consumption of legumes confers cardioprotective benefits (Ros & et al., 
2013).  
Additionally, nuts are rich in unsaturated fatty acids, fiber, vitamins, minerals, 
phytoesterols and PC, all of which are related to CVD protective activity 
(Kris-Etherton et al., 2008). Observational studies and clinical trials have 
suggested that nut intake is beneficial for preventing CVD and has beneficial 
effects on intermediate CVD risk factors such as blood pressure, or total 
cholesterol (Sabaté et al., 2010). Consistent with these studies, in vitro 
studies performed by our group showed that a polyphenol-rich peanut 
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extract reduces extracellular TNF-α, suggesting anti-inflammatory effects 
(Catalán et al., 2012). Recently, the frequency of nut consumption was 
shown to be inversely associated with total and cause-specific mortality, 
independent of other predictors of death (Bao et al., 2013; Ruiz-Canela et 
al., 2014). 
2.2.7 Coffee, tea and cocoa 
Coffee and tea represent the most consumed non-alcoholic beverages 
worldwide and are important dietary sources of PC. Tea consumption may 
have beneficial effects on endothelial function and on total and LDL 
cholesterol. Although the regular consumption of moderate quantities of 
coffee appears to be associated with a weak protection against CVD, 
biological mechanisms by which this consumption might provide 
cardiovascular health benefits remain unclear (Larsson, 2014). 
Cocoa beans and derived products, such as chocolate, contain different 
types of physiologically active compounds including PC such as catechins, 
epicatechins and procyanidins (Di Castelnuovo et al., 2012). In recent years, 
cocoa products have been shown to reduce inflammation, to decrease blood 
pressure and to increase endothelial function and insulin sensitivity 
(Larsson, 2014). 
2.3 DIETARY PATTERNS 
Corresponding to the change from evaluating and treating single risk factors 
to evaluating a person’s total risk profile, many studies focus on dietary 
patterns instead of on single bioactive compounds. Studying the effect of a 
total dietary pattern theoretically shows the full preventive potential of a diet 
because this result yields a combined estimate of the effect of several 
favorable dietary habits. The benefits of the following two dietary patterns on 
CVD risk have been studied in this thesis: Mediterranean diet and healthy 
Nordic diet. 
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2.3.1 Mediterranean Diet 
The MD is based on dietary patterns typical of Crete and other areas of 
Greece and southern Italy in the early 1960s, when the adult life expectancy 
of this region was among the highest in the world and when rates of 
coronary heart disease, certain cancers, and other diet-related chronic 
diseases were among the lowest (Keys et al., 1986). Thus, in 1986, Ancel 
Keys established the MD as the diet traditionally eaten by populations living 
in southern Europe and as a health protecting diet. Subsequently, in 1993, 
Willet presented the MD as a food pyramid reflecting the beneficial 
Mediterranean dietary traditions (Willett et al., 1995). Recently, the MD 
pyramid has been adapted to current lifestyles (Bach-Faig et al., 2011). 
Since these early observations concerning the MD, there have been many 
studies indicating a link between adherence to the MD and a reduced risk of 
overall mortality and of CVD (Tresserra-Rimbau et al., 2014). The MD was 
recommended by the United Nations Education, Scientific and Cultural 
Organization (UNESCO 2010) as a nutritional prototype of worldwide value. 
The MD exerts significant anticancer, cardioprotective, and anti-inflammatory 
activities, which are responsible for lower mortality from coronary heart 
disease and from cancer (Hu et al., 2014). 
The MD is characterized by the following: 1) a high consumption of 
vegetables, legumes, fruit, and cereals; 2) a regular, but moderate, wine 
intake; 3) a moderate consumption of fish and white meat; 4) a moderate 
intake of dairy products; 5) a low consumption of red meat; and 6) a 
relatively high-fat consumption (up to 40% of total energy intake), primarily 
from MUFAs (up to 20% of energy) primarily provided by OO, which is the 
principal source of culinary fat and one of the primary properties of the MD 
(Martín-Peláez et al., 2013). 
The MD is extremely rich in bioactive compounds, particularly in PC, which 
provide the major beneficial health effects related to this dietary pattern 
(Tresserra-Rimbau et al., 2014).  
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2.3.2 Healthy Nordic Diet 
Because the Mediterranean dietary pattern has been associated with a 
decreased incidence of chronic diseases, the MD has been recommended 
as a better dietary alternative for populations in many other Western 
countries. Despite the wide promotion of the Mediterranean dietary pattern, 
the adherence to this diet remains low outside its traditional geographic 
regions. Regional and cultural differences limit adherence to food-based 
diets transferred between populations. Dietary habits vary greatly in different 
parts of Europe, and to be successful, dietary guidelines must be sensitive to 
the local food culture. Correspondingly, populations of northern countries 
have difficulties in integrating the MD into their families’ eating habits. 
Traditionally, the Nordic diet has been and, to some extent, remains 
characterized by food items with positive nutritional profiles, and it can be 
easily adopted by the Nordic population. These traditional Nordic food items 
can, to some extent, be characterized by their origin from Nordic nature 
(Olsen et al., 2011). A healthy Nordic diet, is based on regional foods in 
season and contains rapeseed oil, whole grain, high-fiber cereal products, 
berries, root vegetables, fatty fish and low-fat dairy products (Roswall et al., 
2014). The adherence to a healthy Nordic dietary pattern has been 
associated with lower mortality and has shown beneficial effects on lipid 
profile, low-grade inflammation, insulin sensitivity, blood pressure and, 
therefore, benefits against CVD (Olsen et al., 2011). 
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CHAPTER 3: BIOMARKERS 
3.1 DEFINITION AND CLASSIFICATION OF BIOMARKERS 
In 2001, the National Institutes of Health committee standardized the 
definition of a biomarker as a characteristic that is objectively measured and 
evaluated as an indicator of normal biological processes, pathogenic 
processes, or pharmacologic responses to a therapeutic intervention 
(Biomarkers Definitions Working Group 2001). This definition includes not 
only circulating molecular biomarkers (in serum, plasma, urine, etc.) but also 
genetic, tissue, or cellular markers, imaging results, and physical or 
electronic measurements. However, circulating molecular biomarkers are the 
most attractive because these biomarkers are easy to obtain and generally 
reproducible (Ge et al., 2012). 
Biomarkers are potentially useful along the entire spectrum of the disease 
process. As shown in Figure 6, biomarkers can be classified into five 
categories based on their application in different disease stages (Chen et al., 
2011): 
1. Antecedent biomarkers: to identify the risk of developing an illness. 
2. Screening biomarkers: to screen for subclinical disease. 
3. Diagnostic biomarkers: to recognize overt disease. 
4. Staging biomarkers: to categorize disease severity. 
5. Prognostic biomarkers: to predict future disease course, including 
recurrence, response to therapy, and monitoring efficacy of therapy. 
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Figure 6. Biomarkers during disease evolution. Biomarkers can act at different levels of 
disease stages and, accordingly, can be classified as follows: antecedent biomarkers, screening 
biomarkers, diagnostic biomarkers, staging biomarkers and prognostic biomarkers. 
Biomarkers can indicate a variety of health or disease characteristics, 
including the level and type of exposure to an environmental factor (such as 
chemicals or nutrients), genetic susceptibility, genetic responses to 
environmental exposures, markers of subclinical or clinical disease, or 
indicators of response to therapy (Chen et al., 2011). 
Biomarkers have gained importance and interest in not only basic and 
clinical research but also in clinical practice (Strimbu et al., 2010). 
Technological advances in genomics, transcriptomics, proteomics and 
metabolomics has led to an increasing number of candidate biomarkers with 
potential clinical value. The critical evaluation of the multitude of proposed 
biomarkers is important for identifying those candidates with the strongest, 
most accurate, and reliable information. Accordingly, standards for the 
assessment of novel biomarkers have been proposed to prove clinical 
usefulness. These standards include the quality of the assay (precision, 
availability, and costs), the added value of the novel information in 
comparison with established methods, and the quantifiable value to support 
clinical decision-making (Table 3). 
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Table 3. Phases of evaluating a novel biomarker. 
1 Proof of concept Do novel marker levels differ between subjects with and without disease? 
 
2 Prospective validation Does the novel marker predict disease development in a prospective 
cohort or case-cohort study? 
 
3 Incremental value Does the novel marker add predictive information to the established risk 
marker? 
 
4 Clinical utility Does the novel marker change predicted risk sufficiently to change the 
recommended therapy? 
 
5 Clinical outcome Does using the novel marker improve clinical outcomes, particularly when 
tested in a randomized clinical trial? 
 
6 Cost-effectiveness Does the novel maker improve clinical outcomes sufficiently to justify the 
additional costs of testing and treatment? 
Source: (Doehner, 2012). 
In the future, the integration of biomarkers, identified using emerging high-
throughput technologies, into medical practice will be required to achieve 
personalized treatment and disease prevention (Doehner, 2012). 
3.2 BIOMARKERS FOR CARDIOVASCULAR DISEASE 
As we previously mentioned in Chapter 2, the well-established risk factors 
for CVDs are not sufficient to identify all patients at risk. Certainly, not all 
patients with CVDs will have traditional risk factors and not all patients with 
risk factors will develop CVDs. Thus, the development of new circulating 
molecular biomarkers to diagnose and to prevent CVDs is an important 
public health goal worldwide. Cardiovascular biomarkers have the potential 
to augment clinical risk stratification by assisting in screening, diagnosing 
and assessing the prognosis of patients with and without known CVD risk 
(May et al., 2008). 
Approaches to cardiovascular disease biomarker discovery 
Two different complementary approaches can be used to discover new 
molecular biomarkers for CVDs. The first is a targeted approach based on 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Introduction 
34 
knowledge regarding underlying pathophysiology (deductive method), and 
the second is an unbiased approach (inductive strategy; May et al., 2008).  
The knowledge-based strategy relies on a direct understanding of the 
biological processes that cause the development of atherosclerosis and its 
evolution. Targeted searches for CVD biomarkers are characterized by an 
important focus on molecules from pathways implicated in atherosclerosis, 
including mediators of inflammation, oxidative stress, endothelial function 
and components of the coagulation cascade (May et al., 2008; Vasan, 
2006). A long list of molecular biomarkers related to these key mechanisms 
involved in the onset and progression of atherosclerosis has been 
discovered. Among these biomarkers, 8-hydroxydeoxyguanosine (8-OHdG) 
and oxLDL are commonly used as biomarkers of oxidative stress 
(Valavanidis et al., 2009) and high-sensitivity C-reactive protein (hsCRP) is 
used as an inflammatory biomarker that has been evaluated as potential tool 
for predicting cardiovascular events (Perk et al., 2012). Moreover, VCAM-1 
and E-selectin are common biomarkers for endothelial dysfunction (Paulus 
et al., 2011) and homocysteine and plasminogen activator inhibitor-1 (PAI-1) 
play important roles as thrombotic biomarkers (Aispuru et al., 2012; Perk et 
al., 2012). 
The unbiased approach involves searching through thousands of molecules 
using current technological advances to characterize the biomolecular profile 
of a disease stage. The use of platforms such as genomics, transcriptomics, 
proteomics and metabolomics has been indicated as an ideal method to 
identify new biomarkers in an “unbiased” manner because these platforms 
do not depend on preexisting knowledge of candidate pathways (May et al., 
2008). These omic sciences are used for identifying putative CVD 
biomarkers that may be informative concerning various stages of 
atherogenesis, including overt CVD and its outcome. Technological 
advances will likely facilitate the use of multimarker profiling to individualize 
CVD treatments in the future (Vasan, 2006).   
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3.3 NUTRITIONAL BIOMARKERS 
Nutritional biomarkers are another type of biomarkers not implicated in any 
disease stage. Research interest in these biomarkers has increased in 
recent years to reflect exposure to food intake. 
Reliable dietary assessment methods are crucial when attempting to 
understand the links between specific foods or bioactive compound 
consumption and the risk of chronic diseases, such as CVDs. In nutritional 
studies, collecting valid dietary intake data remains one of the primary 
weaknesses of this type of research. Traditional methods of self-reported 
dietary intake assessment, such as food diaries, food frequency 
questionnaires or 24-hours recalls, present numerous challenges to 
obtaining accurate dietary intake and nutritional status data. This limitation 
can be overcome by the use of nutritional biomarkers, also called 
biomarkers of dietary intake, which are able to objectively assess dietary 
consumption without the bias of self-reported dietary intake errors 
(O’Sullivan et al., 2011). 
Biomarkers of dietary intake are desirable because of their ability to more 
accurately assess nutritional intake or status versus self-reported methods. 
Dietary biomarkers can be used to validate self-reported intake measures, to 
assess the consumption of dietary items when food composition databases 
are inadequate, and to accurately associate dietary intake with disease risk 
and nutritional status. Although dietary biomarkers generally provide a more 
objective measure of dietary intake, factors that may not be present in 
traditional dietary assessment methods could skew biomarker measures of 
dietary intake. Such factors could include genetic variability, lifestyle or 
physiologic factors (e.g., smoking), dietary factors (e.g., nutrient-nutrient 
interaction), biological sample and analytical methodology (Hedrick et al., 
2012). Therefore, the following are criteria that a nutritional biomarker should 
satisfy to validate its usefulness as a dietary biomarker in nutrition studies 
(Puiggròs et al., 2011): 
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1. Robustness of quantification and identification across diverse 
populations. Therefore, sensitive and specific techniques should be 
available to accurately quantify the biomarker of interest, which has 
been appropriately collected and stored to ensure minimum 
biomarker degradation. 
2. Concentrations of the biomarker of interest should be sensitive to 
changes in the intake of the dietary component of interest. 
3. High specificity. Variation in biomarker concentration should be due 
to changes in the intake of the dietary component of interest only. 
4. Comprehension of the effect of physiological factors and whole diet 
composition on the absorption, metabolism and excretion kinetics of 
the putative biomarker. 
 
Depending on its use, a nutritional biomarker should reflect recent intake 
(reflects compliance in shorter-term studies) or should reflect intake over a 
longer period (useful for dietary assessment in epidemiological studies or as 
a compliance marker in longer-term interventions). Hence, it is important to 
select an appropriate biomarker considering the aim of the study (Puiggròs 
et al., 2011). 
In recent years, metabolomics has shown its utility for dietary assessment 
and for the identification of biomarkers of specific dietary intake and, 
consequently, its relation with health status (O’Sullivan et al., 2011). The 
emerging field of metabolomics may help to advance the development of 
nutritional biomarkers. The availability of biomarkers that estimate the intake 
of specific foods and dietary components could greatly enhance nutritional 
research targeting compliance to national recommendations for the 
population, as well as direct associations with disease outcomes. More 
research is required to refine existing biomarkers, to establish new indicators 
of specific food intake, and to develop techniques that are cost-effective, 
noninvasive, rapid and accurate measures of nutritional status. 
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During this thesis, we have worked with both types of biomarkers, circulating 
molecular biomarkers related to CVDs and nutritional biomarkers. 
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CHAPTER 4: OMIC TECHNOLOGIES  
4.1 OMIC TECHNOLOGIES OVERVIEW 
The growth of molecular biology studies, based on omic technologies has 
widely and rapidly expanded during recent decades.  The concept beyond 
omic approaches is that a given biological system can be best determined 
and understood by considering this system in its globality rather than by 
studying its components individually (Rüegg et al., 2008). New high-
throughput omic technologies (such as genomics, transcriptomics, 
proteomics and metabolomics) are allowing detailed studies of molecular 
changes during CVD onset and progression and also during dietary 
interventions (Figure 7). The use of these advanced methods will lead to the 
detection of new disease and nutritional biomarkers, which will provide a 
dynamic and powerful approach for researchers to understand CVD biology 
and the effects of the diet on CVD onset and progression. Moreover, these 
methods will have significant applications in analytic epidemiology, clinical 
trials and prevention, diagnosis, and management of disease (Barallobre-
Barreiro et al., 2013). 
 
Figure 7. Systems biology. Regulatory processes at the DNA level affect the expression of  
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downstream molecules, including RNAs, proteins, and metabolites. The effects of the different 
regulatory elements are additive. Systems biology attempts to analyze the interactions among 
the different molecular entities to offer a holistic view of biological processes and pathological 
changes occurring in disease. Source: (Barallobre-Barreiro et al., 2013). 
All omic studies have shown a typical scheme that has been broadly 
categorized into the following five primary steps: study design, sample 
collection and preparation, data acquisition, data analysis and data mining, 
and biological interpretation. An omic workflow is shown in Figure 8. Omic 
studies generate high-dimensional data sets, complicating the analysis and 
requiring the massive use of mathematical, statistical and computational 
efforts (bioinformatics) and the development of novel analytical tools (Rüegg 
et al., 2008). Data processing is an important step in the data mining 
process from any omic study because this step prevents the presence of 
irrelevant and redundant information, noise and unreliable data that could 
mislead biological interpretation (Ibáñez et al., 2013). 
 
Figure 8. Omic workflow scheme. Source: (adapted from Llorach et al., 2012). 
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4.2 FOODOMICS CONCEPT 
Foodomics has been defined as a new discipline that studies food and 
nutrition domains through applying advanced omic technologies to improve 
consumers’ well-being, health, and confidence (Cifuentes, 2009). Foodomics 
is proposed as a global discipline that includes all of the emerging working 
areas in which food (including nutrition), advanced analytical techniques 
(primarily omics tools), and bioinformatics are combined (Herrero et al., 
2010). Foodomics covers the development of new investigations of 
biomarkers discovery and of food bioactivity and its effect on human health 
(Herrero et al., 2012). The use of omic technologies is a requirement in this 
new discipline. By using this global strategy identifying all the small changes 
induced by bioactive food ingredients on a given system (cell, tissue, organ 
or organism) at different expression levels should be possible (Ibáñez et al., 
2013). An ideal foodomics platform scheme is shown in Figure 9. 
The importance of food for human health is not a new concept; however, 
currently, we are not simply thinking that a good diet is important for health, 
but we can demonstrate this fact, indicating the mechanisms underlying 
these health effects (Capozzi et al., 2013). 
In the last decade, proteomics and metabolomics have contributed 
substantially to our understanding of CVDs and to nutritional biomarker 
discovery (Griffin et al., 2011). Combining proteomics and metabolomics to 
quantify changes in metabolites and proteins will advance our understanding 
of pathophysiological mechanisms for CVDs and the effects of diet on CVD 
onset and progression (Barallobre-Barreiro et al., 2013).  
Metabolomics and proteomics are the omic sciences used for the realization 
of this thesis. Thus, these omic approaches and their applications in nutrition 
and CVD research are explained below in greater detail. 
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Figure 9: Scheme of an ideal foodomics platform to investigate the health benefits of 
dietary constituents on a given biological system. Source: (adapted from Ibáñez et al., 
2012). 
4.3 METABOLOMICS OVERVIEW 
The Metabolomics Society defines metabolomics as a newly emerging field 
of omics research concerned with the comprehensive characterization of the 
small molecule metabolites in biological systems that can provide an 
overview of the metabolic status and global biochemical events associated 
with a cellular or biological system (Mishur et al., 2012; Theodoridis et al., 
2012).  
The term metabolome has been defined as the complete set of metabolites 
or chemicals that can be found in a cell, organ, or organism. In general, 
metabolites are the final downstream products of the genome most closely 
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reflecting the operation of the biological system and its phenotype (Griffin, 
2004). A metabolite is defined as a molecule smaller than 1 kDa. However, 
these small molecules vary significantly in terms of their molecule weights, 
concentrations, polarity, solubility and volatility (Samuelsson et al., 2008). 
Two factors that influence the metabolome have been described: the 
endogenous metabolome, which refers to intrinsic metabolites involved in or 
resulting from metabolism formed under directly derived cell 
genome/proteome control, and the exogenous metabolome, which involves 
all metabolites directly derived from extrinsic factors such as diet, drugs, 
toxics and metabolites produced by the colonic flora (Llorach et al., 2012). 
Bioactive compounds consumption will induce changes in the endogenous 
metabolome, and these effects may be caused by the presence of many 
exogenous metabolites resulting from the digestion of food. These 
exogenous metabolites can be useful as biomarkers of dietary intake 
(Llorach et al., 2012). 
Two analytical platforms are currently used for metabolomics analyses: 
mass spectrometry (MS) and nuclear magnetic resonance (NMR) -based 
systems. These techniques stand alone or are combined with separation 
techniques, such as liquid chromatography (LC), gas chromatography (GC), 
and capillary electrophoresis (CE). Both MS- and NMR-based technologies 
are complementary and, therefore, often used in parallel in metabolomics 
research. Compared with NMR, MS is a more-sensitive technique. 
Additionally, MS coupled to GC, LC, or CE allows higher resolution and 
sensitivity for low-abundance metabolites. Thus, the number of MS-based 
metabolomics studies has grown quickly and now exceeds that of NMR-
based studies (Herrero et al., 2012). The platform for MS analysis consists of 
different units, including the separation unit, which allows the separation of 
highly complex mixtures of analytes into single components before MS 
analysis; the ionization unit, which creates charged particles; the mass 
analyzer unit, which resolves ions formed in the ionization unit according to 
their mass to charge ratio (m/z); the detector unit, which measures the 
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electrical signal coming from the mass analyzer; and the analysis unit, which 
records and coverts signals into MS spectra (Napoli et al., 2013). The use of 
high and ultra-high resolution analyzers, such as, time of flight (TOF), 
Fourier transform mass spectrometry (FTMS), or orbitrap, is essential for 
obtaining accurate mass measurements for determining the elemental 
composition of metabolites (Herrero et al., 2012).  
Metabolomics is an interesting tool for assessing the biological 
consequences of following a nutritional intervention and for assessing food 
consumption. In nutritional interventions, metabolome analysis focuses on 
identifying new biomarkers that allow the intake of certain dietary 
compounds to be monitored and related to their expected biological effect, 
as described in Figure 10 (Llorach et al., 2012). 
 
Figure 10. Metabolomic approach in nutritional interventions. Assessment of nutritional and 
dietary interventions. Source: (adapted from Llorach et al., 2012). 
Two different basic approaches can be used in metabolomic studies: a 
targeted approach and a non-targeted profiling approach. Targeted 
metabolomics refers to a method in which a specified list of metabolites is 
measured, typically focusing on one or more related pathways of interest. 
Non-targeted metabolomics aim to simultaneously measure as many 
metabolites as possible from biological samples and to compare between 
samples without bias (Llorach et al., 2012). 
Targeted analyses of pre-determined sets of clinical biomarkers after the 
consumption of specific health promoting nutrients, foods or diets can 
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provide important mechanistic information; however, these analyses fail to 
provide a larger picture of the altered metabolic status resulting from a 
variety of interactions between food constituents and endogenous 
metabolites (Brennan, 2013). Non-targeted metabolite profiling utilizing 
sensitive and high-throughput analytical technologies offers a wide window 
for monitoring changes in diet-derived and endogenous metabolite levels, 
thus aiding in identifying of novel biomarkers for both dietary intake and 
biological effects (O’Sullivan et al., 2011; Wishart, 2008). Metabolic profiling 
technologies provide a global overview of complex dietary processes, and 
this overview has generated novel insights into the molecular mechanisms 
that shape the relation between diet and CVD risk (Kinross et al., 2014). 
Diet is an important modulator of the human metabolic phenotype, and the 
analysis of the nutritional metabolome will drive the future development of 
personalized nutritional interventions (Kinross et al., 2014). 
4.4 PROTEOMICS OVERVIEW 
Proteomics is the global analysis of the gene expression, function, and 
interaction of the complement of proteins in an organism (Arab et al., 2006). 
Recent advances in proteomic technologies permit the evaluation of 
systematic changes in protein expression in response to intrinsic or extrinsic 
perturbations to the biological system, for example, those perturbations that 
occur in CVDs or that occur after a dietary intervention. The proteome 
encompasses the entire set of proteins expressed by a cell, tissue or 
organism, including their posttranslational modifications (Barallobre-Barreiro 
et al., 2013). 
The increasing popularity of proteomics has created a requirement for 
quantitative analysis methods. Thus, many different techniques are now 
available for performing gel-based or gel-free quantitative proteomics (Bruce 
et al., 2013). These techniques provide insight into global protein 
expression, from identification to quantification. MS is used in these 
strategies as the last analytical step for peptide detection and for protein 
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identification. Currently, MS has become fundamental in proteomic studies 
and represents the most-powerful tool in proteomics because MS requires 
no prior knowledge of the proteins to be identified (Bruce et al., 2013). MS 
also allow the analysis of proteins and peptides in large-scale and high-
throughput modes. Improved mass spectrometers with better sensitivity and 
with superior mass accuracy and resolution aim to identify and to quantify 
complex protein (peptide) mixtures in a single experiment. As we previously 
mentioned in the metabolomics overview section, the versatility of MS 
technologies involves numerous different mass spectrometers, with matrix-
assisted laser desorption/ionization (MALDI)-TOF-TOF, quadrupole-TOF, 
and orbitrap mass analyzers among the common technologies currently in 
use for discovery proteomics (Herrero et al., 2012; Langley et al., 2013). MS 
is not inherently quantitative because of differences in ionization efficiency. 
The most abundant ions will attract the most charges during electrospray 
ionizations, making it less likely for low-level peptides to be ionized. To avoid 
false-positive protein changes due to co-eluting high-abundant peptides, 
labeling techniques should be used for reliable quantification. Popular 
labeling methods in humans include: isobaric tagging for relative and 
absolute quantification (iTRAQ) and tandem mass tags (TMT; Langley et al., 
2013). 
Two primary workflows exist in proteomic studies using MS: top-down and 
bottom-up procedures (Napoli et al., 2013). In top-down procedures, intact 
proteins are pushed into MS-coupled systems, and important data for protein 
characterization are provided, such as molecular mass, post-translational 
modifications, and isoforms. In bottom-up procedures, proteins are purified, 
cut into fragments by chemicals or enzymes and analyzed using MS 
technologies (Napoli et al., 2013). 
Proteomic studies can be performed by either global proteomics approaches 
(non-targeted approach), involving the analysis of many proteins, or the 
selection and analysis of specific types of proteins (targeted approach). 
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Each approach involves choosing the most appropriate experimental 
strategies and technologies (Napoli et al., 2013). 
Proteomic analysis provides an opportunity to understand novel 
pathophysiological mechanisms of CVDs in a non-biased manner. New 
proteomic tools, with systems biology approaches, have the potential to 
unravel greater complexity in previously unexplored signaling networks, 
leading to improved biological understanding of CVD onset and progression 
(Bruce et al., 2013). Proteomic analysis permits the development of a suit of 
putative biomarkers for the increased precision in diagnosis, identification of 
susceptibility to complications, and prognosis personalized to individuals and 
subclassification of disease by pathophysiological manifestations (Bruce et 
al., 2013). Proteomics tools also allow the identification of novel therapeutic 
targets (Arab et al., 2006; Barallobre-Barreiro et al., 2013). 
From a foodomics point of view, comparative proteomics strategies are 
primarily used to obtain an insight on the effect of specific bioactive 
compounds, or diet on the proteome of organisms, tissues, or cells. It is 
interesting to mention that, currently, limited studies remain concerning the 
effects of specific bioactive compounds, or diets on the human proteome 
(Herrero et al., 2012). Proteomics is a key tool for exploring the molecular 
mechanisms involved in the cardioprotective activities of bioactive 
compounds. 
In combinations with other omic technologies, such as transcriptomics and 
metabolomics, proteomics searches different aspects of disease, and the 
different pillars of observations facilitate data integration in disease-specific 
networks. Finally, a systems biology approach may advance our 
understanding of CVD processes at the biological pathway level instead of 
the single molecule level and accelerate progress toward modifying 
interventions for disease prevention (Langley et al., 2013). 
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HYPOTHESIS  
Our hypothesis is that the intake of certain dietary bioactive compounds of 
the Mediterranean and Nordic diets can be assessed and monitored by 
nutritional biomarkers, improving the accuracy of the dietary intake measure. 
Moreover, these dietary bioactive compounds could be associated with an 
important diversity of mechanisms of action and with healthy biological 
effects on molecular biomarkers involved in the development of CVDs, in 
both healthy and CVD risk subjects. 
OBJECTIVES 
The primary objective is to assess the effect of Mediterranean and Nordic 
dietary bioactive compounds, particularly phenolic compounds, on nutritional 
and molecular biomarkers, which allow mechanisms of action and biological 
effects involved in the development of CVDs to be determined.  
The following specific objectives have been set: 
Objective 1: To assess the relations between urinary total polyphenol 
excretion (TPE), which is a biomarker of total polyphenol intake (TPI), 
polyphenol-rich foods, and oxidative stress biomarkers in healthy adults of 
different ages following a MD pattern (Clinical Study 1). 
Objective 2: To assess the modifications of plasma metabolite profiles after 
a healthy Nordic dietary intervention with whole grains, bilberries and fatty 
fish by applying a non-targeted metabolite profiling approach in subjects with 
metabolic syndrome. Furthermore, we aimed to identify novel nutritional 
biomarkers more specific than TPE, and to determine molecular biomarkers 
of endogenous metabolism modified by dietary bioactive compounds 
(Clinical Study 2). 
Objective 3: To assess the impact of a dietary intervention supplemented 
with a virgin olive oil (VOO) or two different functional VOOs enriched with 
their own PC (hydroxytyrosol derivatives) or complemented with thyme PC 
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(flavonoids, monoterpens, and phenolic acids) on the HDL protein cargo and 
on its cardiovascular profile, by applying a quantitative proteomics approach 
in hypercholesterolemic subjects from the Mediterranean area (Clinical 
Study 3). 
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Polyphenol-rich  foods  exhibit  DNA 
antioxidative properties and protect the 
glutathione system in healthy subjects
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Non-targeted  metabol i te  prof i l ing  
discriminates diet-specific biomarkers for 
consumption of whole grains, fatty fish and 
b i l b e r r i e s  - a  r a n d om i z e d  t r i a l
(Sysdimet-HealthGrain intervention)
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
   
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
67 
Non-targeted metabolite profiling discriminates diet-specific 
biomarkers for consumption of whole grains, fatty fish and bilberries – 
a randomized trial (Sysdimet-HealthGrain intervention)
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ABSTRACT 
Background: Non-targeted metabolite profiling allows for concomitant 
examination of wide range of metabolite species elucidating the metabolic 
alterations caused by dietary interventions.    
Objective: The effects of dietary modifications based on increasing 
consumption of whole grains, fatty fish and bilberries on plasma metabolite 
profiles were investigated, in order to identify applicable biomarkers for 
dietary intake and endogenous metabolism. 
Design: Metabolite profiling analysis was performed on fasting plasma 
samples collected in a 12-week parallel group intervention with 106 
participants randomized into three diet interventions: (1) whole grain 
products, fatty fish, and bilberries (Healthy Diet; HD), (2) Whole grain 
enriched diet (WGED), with the same grain products as in HD intervention, 
but with no change in fish or berry consumption, and (3) refined wheat 
breads and restrictions on fish and berries (Control). Additionally, correlation 
analyses were done between the putative biomarker candidates and the 
food intake data for identification of the causative food items.   
Results: Non-targeted metabolite profiling revealed marked differences in 
fasting plasma after the intervention diets as compared to Control. In both 
intervention groups a significant increase was observed in two signals 
identified as glucuronidated alk(en)ylresorcinols and correlating strongly with 
intake of whole grain products. Additionally, HD intervention increased the 
signals for furan fatty acids (CMPF), hippuric acid, and various lipid species 
incorporating PUFAs. In particular, plasma CMPF correlated strongly with 
intake of fish, but not with any other foods. 
Conclusions: Novel biomarkers of intake of health beneficial food items 
included in the Nordic diet were identified by metabolite profiling of fasting 
plasma and confirmed by correlation analyses with dietary records. The 
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most potential of these was CMPF, which was shown to be a highly specific 
biomarker for fatty fish intake.  
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1. INTRODUCTION 
The Nordic diet is characterized by many food items with positive nutritional 
profiles, such as whole grain products, berries, root vegetables, and fatty 
fish. Adherence to a healthy Nordic dietary pattern has been associated with 
lower mortality (1), and controlled interventions using diets modified by 
single food items or combinations of Nordic foods have revealed beneficial 
cardiovascular health effects, i.e. improved lipid profile, glucose metabolism 
and anti-inflammatory properties (2–8). 
The targeted analyses on pre-determined set of clinical biomarkers after 
consumption of specific health promoting nutrients, foods or diets can 
provide important mechanistic information, but they fail to give a broader 
picture of the altered metabolic status resulting from a variety of interactions 
between food constituents and endogenous metabolites. The non-targeted 
metabolite profiling utilizing sensitive and high-throughput analytical 
technologies offers a wide window to monitor changes in diet-derived and 
endogenous metabolite levels, thus aiding the identification of novel 
biomarkers for both dietary intake and biological effects (9–12).  
The Sysdimet-HealthGrain intervention has provided new information of 
potential health effects of whole grain, in particular rye, and of a combination 
of whole grains with bilberries and fatty fish (6,7).  Here we report metabolic 
alterations in fasting plasma, and especially novel biomarkers for 
consumption of whole grain, bilberries and fish, by applying liquid 
chromatography-mass spectrometry based non-targeted metabolite profiling 
approach. Moreover, the link between the observed biomarkers was refined 
to specific food groups by correlation analyses with the dietary intake based 
on repeated food record data. 
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2. MATERIALS AND METHODS 
2.1 Subjects, study design, diets 
The study population was from the Sysdimet-HealthGrain intervention, a 
Finnish randomized controlled dietary intervention (6,7) aiming to investigate 
the effects of the diet rich in whole grains, bilberries and fatty fish on glucose 
metabolism in high risk individuals with impaired glucose metabolism and 
features of the metabolic syndrome. A total of 131 volunteers were recruited 
for a 12-week intervention and randomized to three parallel interventions: 
Healthy Diet (HD), whole-grain-enriched diet (WGED), or control diet 
(Control) (Flow chart available as Online Supplemental Material, 
Supplemental Figure 1). The intervention groups were matched for sex and 
medians of BMI, age and fasting plasma glucose concentration. Altogether 
106 participants completed the study. The baseline characteristics of the 
subjects are available as Online Supplemental Material (Supplemental 
Table 1).  
The intervention diets have been described earlier in detail (6,7). In brief, in 
HD group, the participants were advised to replace their usual cereal 
products by whole grain breads and a bread with low postprandial insulin 
response, and by 3.5 deciliter (measured uncooked) of  whole meal pasta 
per week. The breads recommended contributed 20-25% of the daily energy 
intake. In addition, they were instructed to eat fatty fish (100–150 g fish per 
meal) three times per week, and bilberries (Vaccinium myrtillus; frozen, 
pureed or dried powder) three portions per day (equivalent of 300 g fresh 
bilberries per day). In WGED group, the participants were instructed to 
consume the same cereal products as in HD group and not to change their 
current fish and berry consumption. In Control group, the participants were 
asked to avoid whole grain cereals and consume low-fiber products, intake 
of bilberries was not allowed, and consumption of fatty fish was restricted to 
once a week. Other dietary and lifestyle habits were kept unchanged in all 
groups.  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
73 
The participants kept a 4-day dietary record (consecutive days including one 
weekend day) during the run-in period (baseline) and at weeks 3, 7 and 11 
of the intervention period. The dietary data were analyzed using the 
MicroNutrica® software based on Finnish food composition analyses and 
international food composition tables(13).  
2.2 Non-targeted LC-MS metabolite profiling analysis  
Fasting EDTA plasma samples were collected for the LC-MS metabolite 
profiling analysis (106 at baseline and 106 at the end of the study). An 
aliquot of the sample, 100µL, was mixed with 400 µL of acetonitrile (ACN; 
VWR International, Leuven, Belgium) and mixed in vortex to precipitate the 
proteins, and centrifuged 10 min to collect the supernatant. The supernatant 
was filtered with a 96-well plate (PTFE 0.2 µm) to the collection plate. 
Aliquots of 2 µL were taken from at least half of the plasma samples, mixed 
together in one tube, and used as a quality control sample (QC) for the 
analysis. Additionally solvent blank was prepared in a same manner.  
The samples were analyzed by the UHPLC-qTOF-MS system (Agilent 
Technologies, Waldbronn, Karlsruhe, Germany) that consisted of a 1290 LC 
system, a Jetstream electrospray ionization (ESI) source, and a 6540 UHD 
accurate-mass qTOF spectrometry. The samples were analyzed using two 
different chromatographic techniques, i.e. reversed phase (RP) and 
hydrophilic interaction (HILIC) chromatography. Data were acquired in both 
positive (+) and negative (-) polarity. Sample tray was kept at 4 °C during the 
analysis. Data acquisition software was MassHunter Acquisition B.04.00 
(Agilent Technologies). The QC and the blank were injected after every 12 
samples and also in the beginning of the analysis. The sample order for 
analysis was randomized.  
In RP technique, four microliters of the sample solution was injected onto a 
column (Zorbax Eclipse XDB-C18, 2.1 × 100mm, 1.8 µm, Agilent 
Technologies, Palo Alto, CA, USA) kept at 50 °C. Mobile phases, delivered 
at 0.4 ml/min, consisted of water (eluent A, Milli-Q purified, Millipore, Milford, 
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MA) and methanol (eluent B; Sigma-Aldrich, St. Louis, MO), both containing 
0.1 % (v/v) of formic acid (Sigma-Aldrich, St. Louis, MO). Following gradient 
profile was employed: 0–10 min: 2 → 100% B, 10–15 min: 100% B, 15–15.1 
min: 100 → 2% B; 15.1–18 min: 2% B. 
In HILIC technique, three microliters of the sample solution was injected onto 
a column (Acquity UPLC BEH Amide column, 2.1 × 100mm, 1.7 μm) (Waters 
Corporation, Milford, MA) kept at 45 °C. Mobile phases, delivered at 0.6 
mL/min, consisted of 50% (v/v) (eluent A) and 90% (v/v) (eluent B) 
acetonitrile, respectively, both containing 20 mM ammonium formate, pH 3 
(Sigma-Aldrich, St. Louis, MO). Following gradient profile was as employed: 
0–2.5 min: 100% B, 2.5–10 min: 100% B → 0% B, 10–10.1 min: 0% B → 
100% B; 10.1–14 min: 100% B.  
The MS conditions were as follows after both chromatographies: Jetstream 
ESI source, operated in positive and negative ionization mode, conditions 
were drying gas temperature 325 °C and flow 10 L/min, sheath gas 
temperature 350 °C and flow 11 L/min, nebulizer pressure 45 psi, capillary 
voltage 3500 V, nozzle voltage 1000 V, fragmentor voltage 100 V, and 
skimmer 45 V. For data acquisition, 2 GHz extended dynamic range mode 
was used and the instrument was set to acquire over the m/z 50–1600. Data 
were collected in centroid mode at acquisition rate of 2.5 spectra/s (i.e. 400 
ms/spectrum) with an abundance threshold 150. For automatic data 
dependent MS/MS analyses performed on the QC samples 4 most abundant 
ions were selected for fragmentation from every precursor scan cycle. These 
ions were excluded after 2 product ion spectra and released again for 
fragmentation after a 0.25-min hold. Precursor scan time was based on ion 
intensity, ending at 20000 counts or after 300 ms. Product ion scan time was 
300 ms. Collision energies were 10, 20 and 40 V in subsequent runs. 
Continuous mass axis calibration was performed by monitoring two 
reference ions from an infusion solution throughout the runs. The reference 
ions were m/z 121.050873 and m/z 922.009798 in positive mode and m/z 
112.985587 and m/z 966.000725 in negative mode.  
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2.3 Data analysis 
2.3.1. Collection and statistical analysis of the LC-MS data 
Data was collected using vendor’s software (MassHunter Qualitative 
Analysis B.05.00, Agilent Technologies, USA) and output as compound 
exchange format (cef.files) into the Mass Profiler Professional software  
(MPP 2.2, Agilent Technologies, USA) for compound alignment and data 
preprocessing. Further data processing and selection for the most 
discriminating compounds between diets was performed in Excel (Microsoft 
2007). In order to remove insignificant features, only features found in at 
least 80% of the samples in either at the beginning or at the end of the 
intervention in HD or WGED groups were included in the analysis. This 
resulted in dataset comprising altogether 3130 features found in RP ESI(-) 
(1415), RP ESI(+) (362), Hilic ESI(+) (632), and Hilic ESI(-) (721).  
The difference in the peak area value between the beginning and end of the 
intervention for each participant was determined for each feature in all the 
three dietary groups. A Student’s t-test was used to compare HD and WGED 
groups with Control group in order to find the discriminative features affected 
by either or both of the test diets when compared to the control.  Benjamini–
Hochberg false discovery rate (FDR) was used to adjust results for multiple 
comparisons (14) in each of the four analytical approaches separately, 
taking into account all the features included in each of the pre-processed 
four datasets, resulting in altogether 90 features with pcorr<0.05 (List of the 
differential features is available as Online Supplemental Material, 
Supplemental Table 2). 
Additionally, the pre-processed datasets from each of the four analytical 
approaches were subjected to supervised clustering algorithm Partial Least-
Squares Discriminant Analysis (PLS-DA; Simca-13, Umetrics, Sweden) 
including only the samples collected at the end of the intervention. Data 
were Log10-transformed, pareto-scaled and the model was validated by 
Simca-13 internal cross validation. Further visualization of the data was 
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performed on the RP ESI(-) data matrix containing the features exhibiting 
pcorr <0.05 (74 metabolic features) by the K-means cluster analysis with 
Pearson correlation as distance metric, followed by hierarchical clustering 
within each of the K-means clusters (http://www.tm4.org/mev.html). 
2.3.2. Identification of differential features in the LC-MS data 
The identification of the metabolites was based on MS/MS spectral 
comparison of pure standard compounds and the search of candidate 
compounds in databases including the Human Metabolome database, 
METLIN, ChemSpider and SciFinder, and verified with MS/MS spectral 
features included in the databases or reported in earlier publications. Lipids 
were identified based on MS/MS fragmentation when the metabolite was 
intensive enough to be caught in the automatic data dependent MS/MS 
analysis. The fragmentation pattern for phosphocholines (PCh) and 
phosphoetanolamines (PE) follows what has been published (15–17).  Key 
elements for identification are the protonated head group (m/z 184.07 for 
PChs and m/z 196.03 for PEs) as well as the deprotonated PUFA fragments 
visible in the negative ionization mode (MS/MS fragmentation data for all of 
the identified metabolites is available as Online Supplemental Material, 
Supplemental Table 3.). The plasmalogen was identified based on the head 
group indicating PCh as well as the m/z 303 corresponding to arachidonic 
acid (C20:4) with links in Metlin solely for plasmalogens for the mass 
765.579. Glucuronidated alk(en)ylresorcinols were identified based on 
MSMS fragmentation and compared to published data as described in the 
Online Supplemental Material (Supplemental Figure 2). 
2.3.3. Clinical characteristics and dietary intake 
Linear mixed-effect models were used to analyse group differences in 
clinical characteristics and dietary intake in the baseline and during the 
intervention as reported earlier (6). Analyses were performed using R 
Project for Statistical Computing version 2.7.2 (http://www.R-project.org) and 
nlme R-package version 3.1-96 (18). Interaction term between group and 
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intervention time-point (before or after intervention) was used to examine 
group related changes during the intervention. Control group was used as a 
reference group when comparing group differences. Benjamini–Hochberg 
false discovery rate (FDR) was used to adjust results for multiple 
comparisons (14). 
2.3.4. Correlations between biomarker candidates and recorded dietary 
intake 
Spearman rank correlation coefficients were calculated for relationships 
between the change in daily intake of whole grain bread, berries and fish, 
and change in peak abundance of selected biomarker candidates resulting 
from the statistical analysis.  All subjects were included in the correlation 
analyses (n=106). Furthermore, analysis of variance was used (ANCOVA) 
with standardized values in order to study associations between selected 
biomarkers and food intake taking the effect of whole intervention diet into 
account (corrected by the intervention group). Stepwise linear regression 
model was applied in order to test the individual and combined associations 
of CMPF, EPA and DHA (independent variables) with the consumption of 
fish (dependent variable).  The level of statistical significance was set at p < 
0.05. Correlations were analyzed using the Statistical Package for the Social 
Sciences (SPSS) for Windows (19.0 version; IBM Corp., Armonk, NY, USA). 
3. RESULTS 
3.1. Clinical characteristics and dietary intake 
The clinical characteristics and dietary intakes have been reported in detail 
earlier, and there were no significant changes in measured characteristics 
during the study (Supplemental Table 1) (6,7). During the interventions, HD 
and WGED groups consumed the whole grain and low insulin response rye 
breads 7.7, and 7.9 portions per day, respectively, and Control group white 
wheat breads 6.8 portions per day, resulting in significantly higher fiber 
intake in HD and WGED groups as compared to Control group 
(Supplemental Table 1). In HD group, the mean fish consumption was 3.3 
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fish meals per week, resulting in an increased intake of eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA) (Supplemental Table 1). 
Intake of bilberries in HD group was 3.2 portions per day (Supplemental 
Table 1). Thus the self-reported compliance with the diets was good.  
3.2. Identification of statistically significant biomarkers  
The non-targeted metabolite profiling revealed metabolic changes in the 
fasting plasma of the participants in HD and the WGED groups when 
compared to Control group. Out of the 3130 molecular features collected in 
the four different LC-MS modes, altogether 400 were found to have 
significant changes during the intervention with either one or both of the 
intervention diets when compared to Control group (Student’s t-test, p < 
0.05). After correcting for the multiple measurements within each of the four 
analytical approaches, the number of metabolic features with significant 
change was 90 (pcorr <0.05, Supplemental Table 2). The metabolites 
amenable for identification based on the automatic data dependent MS/MS 
analysis are listed in Table 1 with results from the statistical analysis, and 
the MS/MS spectral fragmentation data can be found in Supplemental Table 
3. The metabolites with pcorr <0.05 are herein discussed as statistically 
significant features, whereas those having p<0.05 but not statistically 
significant after FDR correction are termed as metabolites having a trend.  
A particularly clear change in the fasting plasma lipid profile after the HD 
period was the accumulation of 3-carboxy-4-methyl-5-propyl-2-
furanpropanoic acid (CMPF) (2.56-fold; pcorr=1.98x10
-6
). It was identified 
based on fragmentation match in Metlin and verified with the pure standard 
compound. Interestingly, in the near vicinity of the CMPF metabolite, there 
was another compound with m/z 267.1234 exhibiting the very same 
fragmentation pattern and also regarded as significant marker in RP ESI(-) 
analysis (1.22-fold; pcorr =0.033). The fragmentation and the elemental 
composition suggested a compound with an additional C2H4 in the molecular 
structure, which would refer to a two carbon units longer side chain in the 
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position 1 in the furan backbone of the metabolite. SciFinder browsing 
suggested such a compound, namely 3-carboxy-4-methyl-5-pentyl-2-
furanpropionic acid, reported earlier in sources including uremic serum (19) 
as well plant material (20). 
Another prominent change in the fasting plasma in HD group was an 
increase in hippuric acid (21) (3.3-fold; pcorr =0.0006). Other phenolic 
metabolites, like pyrocatechol sulfate, were also increased in HD group (2.0-
fold; pcorr =1.98x10
-6
). The other metabolites affected by HD diet were 
phosphatidylcholines (PCh), lysophosphatidylcholines (LPC) and 
lysophosphatidyl-ethanolamines (LPE) with long chain PUFAs. HD 
intervention clearly increased e.g. LPC (20:5) with two isomers (both 1.7-
fold; pcorr =0.0001), LPE(20:5) (1.6-fold; pcorr <0.0016), and LPE(20:6) (1.1-
fold; pcorr =0.024). As expected, EPA (C20:5) and DHA (C22:6) fatty acids 
were also increased in HD group (1.5-fold; pcorr =0.0025 and 1.3-fold; pcorr 
=0.0039, respectively).  
Whereas multiple metabolic markers were found in HD group, in WGED 
group there were only two metabolites with significant p-values after the 
strict FDR correction. These were statistically significant also after HD diet. 
The signals were two closely eluting peaks with m/z values of 551.3581 (1.2-
fold; pcorr=0.0004) and 577.3737 (1.2-fold; pcorr =1.98x10
-6
). Under MS/MS 
fragmentation both metabolites showed neutral loss of glucuronide, and the 
aglycon masses matched with alkylresorcinol (AR) 5-Nonadecyl-1,3-
benzenediol for the compound with m/z 551.3581 and alkenylresorcinol 5-
(16-Heneicosenyl)-1,3-benzenediol for the aglycon of the compound with 
m/z 577.3737. Further examination with the MS/MS spectra showed 
identical fragmentation with the published ones with these candidate 
metabolites (22,23), and although the exact position of the double bond in 
the molecule was not determined, the compounds were identified as 
Nonadecyl-benzenediol glucuronide (AR C19:0-Gln) and  Heneicosenyl-
benzenediol-glucuronide (AR C21:1-Gln) (Table 1, Supplemental Figure 2).  
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In addition to the glucuronidated alk(en)ylresorcinols, there was a trend 
towards altered metabolism of various betaine compounds in WGED group 
(Table 1). The retention between 2-3 minutes in the HILIC ESI(+) had 
numerous signals exhibiting betaine-like fragments in the MS/MS analysis, 
out of which a few could be identified based on earlier knowledge on 
occurrence of betaine in human biofluids (21,24,25). Among the identified 
betaine metabolites was pipecolic acid betaine which showed increased 
trend in both HD and WGED groups (1.3-fold; p=0.035 and 1.9-fold; 
p<0.0077, respectively). Interestingly, the peaks of two main betaine 
compounds, glycine-betaine and proline-betaine, with very large inter-
individual variation did not differ between HD and WGED groups. On the 
contrary, analogous metabolites eluting shortly after both peaks with exactly 
same mass and similar fragmentation pattern, had differential trend in 
WGED group when compared to Control, namely m/z 144.1025, rt 3.95 and 
m/z 118.0619, rt 5.53 (Table 1). Propionylcarnitine and -butyrobetaine 
metabolites were increased in WGED group when compared with Control 
group (1.2-fold; p=0.043 and 1.1-fold; p=0.012, respectively). Furthermore, 
there were also increases in the levels of certain amino acids such as L-
lysine, ornithine, and L-arginine in WGED group when compared with 
Control group (1.6-fold; p=0.0094, 1.2-fold; p=0.0043, and 1.2-fold; 
p=0.0097, respectively).  
3.3. Classification of the LC-MS data by chemometrical analyses  
The end-point samples from all of the intervention participants were 
subjected to the chemometric algorithm Partial Least Squares Discriminant 
Analysis (PLS-DA) as exemplified with the data from the RP ESI(-) mode 
(Figure 1). The clustering of the samples in the PLS-DA analysis was in line 
with the statistical analyses, since the samples collected at the end of HD 
intervention differ from the other diets (Figure 1A). Furthermore, as 
visualized by the loadings plot, the most discriminating metabolites for the 
study groups in the PLS-DA model are the same compounds that were 
identified as putative biomarkers between the study diets also by the 
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statistical analysis (Figure 1B). Variable influence on projection (VIP) values 
for e.g. hippuric acid, pyrocatechol sulphate and CMPF were 2.46, 2.56, 
1.94, respectively, indicating that these compounds are among the most 
powerful discriminators between HD group and the two other groups. 
Additionally, from the loadings plot several unknown lipid metabolites were 
noticed based on mass and retention time, e.g. MW 869.539, rt 11.8, VIP 
1.76, which contributed to the clustering of Control group, as well as a 
smaller metabolite of unknown identity MW 188.094, rt 3.3, VIP 1.81. These 
metabolites are most likely endogenous compounds that are at higher level 
in Control group than in the test groups.  
74 features in RP ESI(-) had pcorr <0.05, and were subjected to K-means 
cluster algorithm followed by hierarchical cluster analysis with a heat map 
output (Figure 2). When the fold change values for the statistically 
significant features were included in the analysis, seven clusters were 
formed based on the similar response profile throughout the study 
participants (three markers did not cluster with any of those and were 
removed from the analysis). Cluster 1 contained two metabolites, hippuric 
acid and pyrocatechol sulfate, and cluster 2 held the two alk(en)ylresorcinol 
glucuronides. In cluster 3, there was a group of unknown lipids with retention 
time over 12 minutes increased in HD group, but tended to be increased 
also in the participants of WGED group.  The fourth group clustered mainly 
the EPA and DHA fatty acids with several fragment ions, as well as the 
CMPF metabolite, likewise with several fragments. However, the other furan 
fatty acid (3-carboxy-4-methyl-5-pentyl-2-furanpropionic acid) grouped 
together with the AR-metabolites in cluster 2.  Cluster 5 contained various 
lipid metabolites that were increased in particular after the HD intervention, 
including the identified lipids LPE(20:5), LPE(22:6), and two isomers of 
LPC(20:5), as well as several unknown metabolites that had lower signal 
intensity and were not amenable for the identification based on the 
automatic data dependent MS/MS analysis. Cluster 6 had unknown lipid 
metabolites that were increased in HD group, and were completely 
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undetected in majority of the participants of WGED and Control groups. 
Cluster 7 was formed from unknown metabolites, mostly lipids based on the 
rt, that were seemingly decreased after the HD intervention.  
3.4 Association between changes in plasma biomarkers and 
consumption of selected food items  
After identifying the strongest putative biomarker metabolites for the 
intervention groups, we wanted to determine which foods specifically are 
associated with the increased levels of those metabolites by conducting 
correlation analyses with the food intake data collected during the 
intervention. Among the most significantly changed metabolites in the HD 
intervention was CMPF. We found very strong positive associations between 
plasma CMPF and recorded fish intake (Table 2). The association was 
stronger with total fish intake than with fatty fish intake only. However, there 
was no significant association between plasma CMPF and the intake of lean 
fish, possibly because the consumption of lean fish was limited due to the 
design of the original study.   
Cross-sectionally, plasma CMPF associated also with the intake of berries at 
baseline (beta= 0.291, p=0.003) and at the end of the intervention 
(beta=0.363, p=0.001), (Table 3). However, there was no association 
between the changes in the intake of berries and changes in plasma CMPF 
when adjusted with the effect of intervention group (Table 2). Plasma CMPF 
levels did not associate positively with the intakes of grain products, fruits, 
vegetables, milk products, meat, potatoes, nuts, eggs or oils and spreads 
(Table 2). Intakes of berries and fish correlated especially at the end of the 
study (r=0.524, p=8.2 x 10
-9
 vs. at baseline r=0.096, p=0.328), since the 
participants in the Healthy Diet group were advised to increase their intake 
of both fish and berries during the intervention. To account for this, the effect 
of intervention group was included into the model when analyzing 
associations between dietary intake and plasma CMPF cross-sectionally at 
the end of the study, and when comparing the respective changes during the 
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intervention period. Furthermore, we applied a linear regression model in 
which both the intake of berries and fish were included. In this analysis, 
changes in fish intake had an independent effect on changes in plasma 
CMPF when intake of berries was included in the model (beta=0.473 and 
p=7 x 10
-8
), but also berries seemed to have an independent effect on 
plasma CMPF (beta=0.290, p=0.001). However, in this model, the effect of 
fish intake on plasma CMPF level was 5-fold compared to the effect of 
berries. 
We also tested the associations of plasma CMPF level with calculated 
dietary intakes of EPA and DHA and with plasma levels of EPA and DHA, 
the established biomarkers of fish intake. We found a strong positive 
correlation between plasma CMPF and EPA and DHA at baseline, at the 
end of the study, and between the respective changes during the 
intervention (Table 3). Using stepwise linear regression model we observed 
that plasma CMPF is even stronger independent predictor for fish 
consumption than plasma EPA (for CMPF beta=0.402, p=7x10
-5
; for EPA 
beta=0.212, p=0.031). DHA did not predict fish consumption significantly. 
The adjusted R-square for the model that included only plasma CMPF was 
0.261, and for the model including both CMPF and EPA 0.294, indicating 
that EPA improves the prediction of fish consumption for by only 3 %.  
Associations between the consumption of specific food items were evaluated 
also for several other biomarker candidates including hippuric acid and 
alk(en)ylresorcinol glucuronides (Table 4). The associations between the 
respective biomarkers at the end of the intervention period are illustrated by 
plotting the peak area as a function of reported consumption of specific food 
(Figure 3).  A significant correlation was observed between the change in 
peak abundance of plasma hippuric acid and change in daily intake of 
bilberries, but not with the change in whole grain intake (Table 4). The alkyl- 
and alkenylresorcinol-glucuronides, which were increased both in HD and 
WGED groups, associated strongly positively with the intake of whole grain 
bread, but also with the intake of berries (Table 4). The correlation with berry 
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consumption was, however, a consequence of the concurrent consumption 
of whole grain and berries in HD group, since after inclusion of the 
intervention group in the model, there was no longer association between 
the alk(en)ylresorcinol glucuronides and the intake of berries (beta=0.073 
and p=0.510). Additionally changes in betaines correlated positively with the 
changes in the intake of whole grain bread (Table 4). Of all betaines, 
pipecolic acid betaine had the strongest correlation with the intake of whole 
grain bread (r=0.343, p=4x10
-4
).   
4. DISCUSSION 
Using the non-targeted metabolite profiling with LC-MS analytics, we were 
able to show the concomitant changes in metabolite levels after two partially 
overlapping dietary modifications, i.e. the whole grain enriched diet (WGED) 
and the diet rich in bilberries and fatty fish in addition to whole grains (HD). 
After strict statistical filtering, 90 molecular features (out of 3130 detected) 
were found to have significant changes during either one or both of the 
intervention groups when compared to Control diet. In the HD intervention, 
the most important findings included the impact of fatty fish in particular on 
the plasma levels of furan fatty acids (CMPF) and on various PUFA 
containing lipids, as well as the remarkable increase in fasting plasma 
hippuric acid level (reflecting increased consumption of bilberries). 
Additionally, two novel biomarkers of whole grain consumption, the 
glucuronidated alk(en)ylresorcinols, were found in the interventions with 
whole grain products, particularly rye. Furthermore, we identified CMPF as a 
potential biomarker for fatty fish intake. The K-means cluster analysis on the 
fold change values classified the metabolic features having similar 
occurrence in all the study participants, further elaborating the general 
metabolic responses to the test diets. Betaine and amino acid metabolism 
also tended to be altered in both intervention groups. 
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CMPF correlated strongly with the intake of fish but not with other 
foods 
The plasma level of CMPF was strongly affected by the HD diet, and 
correlation analyses with food intake data showed an association with the 
intake of fish but not with other foods. The association with intake of berries 
was most likely due to the concomitant increase in the consumption of fish 
and berries, since no correlations between the respective changes during 
the intervention were found.  CMPF belongs to furan fatty acids, and fish is 
their richest source in human diet (26). However, small concentrations of 
furan fatty acids have also been measured in green plants, champignons, 
algae, vegetable oils and butter (20,26), but these foods were not associated 
with fasting plasma CMPF level in our study. The most likely origin for 
plasma CMPF are the fish-borne furan fatty acids, although the metabolic 
conversions are not precisely described (27). 
In our study, plasma CMPF was a stronger marker for fish intake than the 
established biomarkers EPA and DHA. Furthermore, a model including both 
plasma CMPF and EPA was not able to predict fish intake considerably 
better than plasma CMPF alone.  Analytically, plasma CMPF is a good 
candidate for a biomarker molecule to be quantified by a targeted 
measurement. It elutes in the C18 reversed phase LC column before the 
fatty acids and phospholipids, exhibiting excellent retention as evidenced by 
the sharp peak shape. Moreover, its ionization efficiency is free from the ion 
suppression risk associated with LC-MS analysis of metabolites co-eluting 
with the phospholipids. These facts support the potential application of 
plasma CMPF as an alternative for EPA and DHA. Indeed, several published 
targeted LC-MS protocols are available for measurement of plasma CMPF in 
renal failure (28,29), and they could be easily adjusted for utilization as 
straightforward biomarker analysis for nutritional assessment purposes. 
Overall, the impact of the HD diet on the endogenous lipid profile was very 
extensive, as demonstrated here with the statistical and chemometric 
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analyses showing lipid species that were decreased in HD group.  Several 
findings on the lipids also confirmed our earlier results of lipidomics analysis 
on the same sample set (6), i.e. increase in EPA, DHA, LPC(22:6), and LPC 
(20:5), but we discovered some additional lipid species with increase in 
response to the HD diet, such as LPE(22:6) and LPE(20:5).  
Glucuronidated alk(en)ylresorcinols were the most prominent whole 
grain specific biomarkers  
Glucuronidated alk(en)ylresorcinols were identified as significant biomarkers 
after both intervention diets, and AR C21:1-Gln was among the most 
important variables contributing to the PLS-DA model clustering of the end-
point samples of the WGED intervention. Additionally, we found a strong 
positive correlation between the change in plasma levels of glucuronidated 
alk(en)ylresorcinol and change in consumption of whole grain bread.  
The chromatographic conditions of our non-targeted analysis were most 
likely not suitable for analysing the intact alkylresorcinols, but the 
glucuronidated forms are more water–soluble and thus detectable in our 
analysis, and reported here for the first time in human plasma. 
Alkylresorcinols are phenolic lipids with 3,5-dihydroxy-5-alkylbenzene 
configuration found predominantly in the bran part of rye and wheat, and are 
well established biomarkers of intake of whole grain rye and wheat products 
(30). They can be measured by GC-MS method from urine and plasma 
following whole grain intake (31). The detection of glucuronidated 
alk(en)ylresorcinols in fasting plasma readily after protein precipitation in 
regular RP-MS conditions could offer a straightforward alternative to the 
presently applied analytical methods. 
Interestingly, one of the glucuronidated AR markers has the C21:1 alkenyl 
side chain, thus exhibiting one double bond in the carbon tail. Both 
alkenylresorcinols and alkylresorcinols have been reported in rye and wheat 
(22,23), but thus far only alkylresorcinols have been discussed as dietary 
biomarkers. Our semi-quantitative analysis does not allow estimation of the 
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proportional amount of the glucuronidated ARs when compared to the 
regularly measured free forms (31).  
We were unable to detect two main end products of endogenous metabolism 
of alkylresorcinols, 3,5-dihydroxybenzoic acid (3,5-DHBA) and 3-(3,5-
dihydroxyphenyl)propanoic acid (3,5-DHPPA), which have been found in 
urine, plasma, and bile in either free or glucuronide or sulfate conjugated 
forms following intake of whole grain rye and/or wheat (32,33). Furthermore, 
glucuronidated and sulfated alkylresorcinol metabolites with novel structures, 
such as 5-(3,5-dihydroxyphenyl)pentanoic acid (3,5-DHPPTA) and 2-(3,5-
dihydroxybenzamido)acetic acid (3,5-DHBA glycine) have been detected in 
human and mouse urine postprandially (34), and 2,6-DHBA has been 
reported as fasting plasma biomarker after a fiber-enriched dietary 
intervention (35). The estimated half-lives for alkylresorcinols in plasma 
range between 5 to 8 hours (36). Therefore it is possible that the 
glucuronidated forms of the alk(en)ylresorcinols reported here display 
different bioavailability, metabolism and kinetics in humans than the 
metabolites reported earlier.  
Healthy diet induced increase in fasting plasma hippuric acid levels  
Hippuric acid and pyrocatechol sulfate were among the most prominent 
metabolites of dietary related polyphenols that were increased in the fasting 
plasma in HD group. Since hippuric acid level was not altered in WGED 
group, bilberries and bilberry products were the likely sources for increased 
hippuric acid levels in HD group, and this was actually confirmed with the 
correlation analyses based on the food record data. 
Several studies have reported elevated hippuric acid levels in urine after 
ingestion of polyphenol-rich foods and drinks, such as red wine, grape juice, 
black and green tea, cranberries, and blackcurrant juice (37–40), and the 
hippuric acid levels in 24-hour urine have been proposed as a potential 
biomarker for fruit and vegetables consumption (41).  However, data on 
changes in plasma levels of hippuric acid and other phenolic acids in 
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response to diet are limited. An increasing trend has been reported following 
daily consumption of green tea over a 3-6 week period (42), and similarly 
after a single dose of blackcurrant juice (40). Earlier reports indicate that 
excretion of phenolic acids and hippuric acid is increased after intake of 
bilberry anthocyanins, indicating that the anthocyanins are most likely the 
source for the elevated levels of phenolics in fasting plasma also in our study 
(43,44). 
We did not observe elevated levels of hippuric acid after WGED intervention, 
indicating different metabolism of the phenolics from this source than 
phenolics from berries. These results are in concordance with our earlier 
report, showing no differences in urinary excretion of hippuric acid after 
ingestion of rye bread and white wheat bread (45). Even though hippuric 
acid is regarded as biomarker for dietary intake of phenolics, polyphenol 
metabolism by intestinal microbiota and liver can produce numerous other 
metabolites into the circulation (46).  
Whole grain consumption caused alterations in amino acid and betaine 
metabolism 
WGED intervention tended to increase fasting plasma levels of several 
amino acids such as L-lysine, L-arginine, and ornithine in accordance with 
an earlier report on plasma amino acids as potentially useful biomarkers for 
intake of grain protein (47). Additionally, changes in essential amino acids 
such as phenylalanine and tyrosine have been observed postprandially after 
the intake of a sourdough fermented endosperm rye bread (48).  
The diets enriched with whole grains tended to increase also betaine 
compounds in fasting plasma, and betaines associated positively with the 
intake of whole grain bread in the intervention groups. Whole grain products 
are known to be a major source of dietary betaine (49), and several 
metabolomics studies have reported increased plasma betaine levels and 
altered metabolism following whole grain intervention(50–53). In our study, 
the number of altered betaine-specific MS/MS signals was high, but many 
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were not identified and need to be investigated using modified analytical 
conditions. The high diversity of betaines and the large inter-individual 
variation is most likely due to altered endogenous metabolism of betaines 
after the increased consumption of whole grain products. Among the 
identified betaines, pipecolic acid betaine associated strongest with the 
consumption of whole grain bread, although it has not been reported as 
constituent of whole grains, but only in citrus genus plants (54). One 
potential metabolic route for the increase of pipecolic acid betaine level in 
fasting plasma in WGED group is the endogenous catabolism of lysine by 
intestinal bacteria, which was also increased in this study group (21,55). To 
our knowledge, pipecolic acid betaine has not been identified in human 
plasma earlier. Additionally, -butyrobetaine and propionylcarnitine were 
increased in the WGED group, as was reported also in our earlier work on 
betaine supplementation in mice (56).  
Conclusion 
Novel biomarkers for intakes of selected food items included in the Nordic 
diet were identified in fasting plasma using the non-targeted LC-MS 
metabolite profiling. Correlation analyses further verified the associations of 
1) CMPF with increased consumption of fatty fish, 2) the glucuronidated 
alk(en)ylresorcinols with consumption of whole grains, and 3) hippuric acid 
with intake of bilberries, thus suggesting them as biomarkers of intakes of 
these healthy foods. Furthermore, the observations of altered endogenous 
metabolism of betaine, amino acids and lipids can indicate potential 
beneficial effects of a healthy Nordic diet, rich in whole grains, fatty fish and 
berries.  
5. AKNOWLEDGEMENTS 
We thank T. Onnukka and K. Kettunen (laboratory technicians), M. 
Puttonen, K. Riekkinen and L. Joukamo (research assistants), and T. 
Jääskeläinen and J. Lappi (dietitians) from the Department of Clinical 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
90 
Nutrition, University of Eastern Finland, Kuopio, Finland, Miia Reponen is 
thanked for maintaining the LC-MS-qTOF instrument. Dr Rikard Landberg 
and Dr Alastair Ross are acknowledged for the discussions on 
alkylresorcinol metabolites. The authors declare having no conflicts of 
interest. 
  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
91 
6. REFERENCES 
1.  Olsen A, Egeberg R, Halkjær J, Christensen J, Overvad K, Tjønneland A. Healthy 
aspects of the Nordic diet are related to lower total mortality. J Nutr. 2011;141(4):639–
44.  
2.  Juntunen KS, Laaksonen DE, Poutanen KS, Niskanen LK, Mykkänen HM. High-fiber 
rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am 
J Clin Nutr. 2003;77(2):385–91. 
3.  Laaksonen DE, Toppinen LK, Juntunen KS, Autio K, Liukkonen K-H, Poutanen KS, et 
al. Dietary carbohydrate modification enhances insulin secretion in persons with the 
metabolic syndrome. Am J Clin Nutr. 2005;82(6):1218–27. 
4.  Adamsson V, Reumark A, Fredriksson I-B, Hammarström E, Vessby B, Johansson G, 
et al. Effects of a healthy Nordic diet on cardiovascular risk factors in 
hypercholesterolaemic subjects: a randomized controlled trial (NORDIET). J Intern 
Med. 2011;269(2):150–9. 
5.  Kolehmainen M, Mykkänen O, Kirjavainen P V, Leppänen T, Moilanen E, Adriaens M, 
et al. Bilberries reduce low-grade inflammation in individuals with features of metabolic 
syndrome. Mol Nutr Food Res. 2012;56(10):1501–10. 
6.  Lankinen M, Schwab U, Kolehmainen M, Paananen J, Poutanen K, Mykkänen H, et al. 
Whole grain products, fish and bilberries alter glucose and lipid metabolism in a 
randomized, controlled trial: the Sysdimet study. PLoS One. 2011;6(8):e22646. 
7.  De Mello VDF, Schwab U, Kolehmainen M, Koenig W, Siloaho M, Poutanen K, et al. A 
diet high in fatty fish, bilberries and wholegrain products improves markers of 
endothelial function and inflammation in individuals with impaired glucose metabolism 
in a randomised controlled trial: the Sysdimet study. Diabetologia. 2011;54(11):2755–
67. 
8.  Uusitupa M, Hermansen K, Savolainen MJ, Schwab U, Kolehmainen M, Brader L, et 
al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and 
inflammation markers in metabolic syndrome -- a randomized study (SYSDIET). J 
Intern Med. 2013;274(1):52–66. 
9.  Brennan L. Metabolomics in nutrition research: current status and perspectives. 
Biochem Soc Trans. 2013;41(2):670–3. 
10.  O’Sullivan A, Gibney MJ, Brennan L. Dietary intake patterns are reflected in 
metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr. 
2011;93(2):314–21. 
11.  Wishart DS. Metabolomics: applications to food science and nutrition research. Trends 
Food Sci Technol. 2008;19(9):482–93. 
12.  Llorach R, Garcia-Aloy M, Tulipani S, Vazquez-Fresno R, Andres-Lacueva C. 
Nutrimetabolomic strategies to develop new biomarkers of intake and health effects. J 
Agric Food Chem. 2012;60(36):8797–808.  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
92 
13.  Rastas M, Seppänen R, Knuts L, Karvetti R VP. Ruokien ravintoainesisältö (Nutrient 
composition of foods). Turku: Social insurance Institution. 4th ed. 1997.  
14.  Benjamini Y HY. Controlling the False Discovery Rate: A Practical and Powerful 
Approach to Multiple Testing - controlling_fdr_benjamini95.pdf. J R Stat Soc Ser B. 
1995;57:289–300.  
15.  Buré C, Ayciriex S, Testet E, Schmitter J-M. A single run LC-MS/MS method for 
phospholipidomics. Anal Bioanal Chem. 2013;405(1):203–13.  
16.  Xia Y-Q, Jemal M. Phospholipids in liquid chromatography/mass spectrometry 
bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring 
plasma phospholipids, the effect of mobile phase composition on phospholipids elution 
and the association of phos. Rapid Commun Mass Spectrom. 2009;23(14):2125–38. 
17.  Murphy RC, Axelsen PH. Mass spectrometric analysis of long-chain lipids. Mass 
Spectrom Rev. 2011;30(4):579–99.  
18.  Pinheiro J, Bates D, DebRoy S SD. Linear and Nonlinear Mixed Effects Models. 2009.  
19.  Niwa T, Takeda N, Maeda K, Shibata M, Tatematsu A. Accumulation of furancarboxylic 
acids in uremic serum as inhibitors of drug binding. Clin Chim Acta. 1988;173(2):127–
38.  
20.  Hannemann K, Puchta V, Simon E, Ziegler H, Ziegler G, Spiteller G. The common 
occurrence of furan fatty acids in plants. Lipids. 1989;24(4):296–8.  
21.  Fujita T, Hada T, Higashino K. Origin of D- and L-pipecolic acid in human physiological 
fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading 
test. Clin Chim Acta. 1999;287(1-2):145–56. 
22.  SUZUKI Y, ESUMI Y, URAMOTO M, KONO Y, SAKURAI A. Structural Analyses of 
Carbon Chains in 5-Alk(en)ylresorcinols of Rye and Wheat Whole Flour by Tandem 
Mass Spectrometry. Biosci Biotechnol Biochem. 1997;61(3):480–6.  
23.  Zhu Y, Conklin DR, Chen H, Wang L, Sang S. 5-alk(en)ylresorcinols as the major 
active components in wheat bran inhibit human colon cancer cell growth. Bioorg Med 
Chem. 2011;19(13):3973–82. 
24.  Holm PI, Ueland PM, Kvalheim G, Lien EA. Determination of choline, betaine, and 
dimethylglycine in plasma by a high-throughput method based on normal-phase 
chromatography-tandem mass spectrometry. Clin Chem. 2003;49(2):286–94.  
25.  Bruce SJ, Guy PA, Rezzi S, Ross AB. Quantitative measurement of betaine and free 
choline in plasma, cereals and cereal products by isotope dilution LC-MS/MS. J Agric 
Food Chem. 2010;58(4):2055–61. 
26.  Vetter W, Wendlinger C. Furan fatty acids - valuable minor fatty acids in food. Lipid 
Technol. 2013;25(1):7–10. 
27.  Toshimitsu N. 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid. In: Desiderio, DM 
and Nibbering N, editor. Uremic toxins. John Wiley. New Yersey; 2012. p. 87–9.  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
93 
28.  Watanabe H, Miyamoto Y, Otagiri M, Maruyama T. Update on the pharmacokinetics 
and redox properties of protein-bound uremic toxins. J Pharm Sci. 2011;100(9):3682–
95. 
29.  Boelaert J, Lynen F, Glorieux G, Eloot S, Van Landschoot M, Waterloos M-A, et al. A 
novel UPLC-MS-MS method for simultaneous determination of seven uremic retention 
toxins with cardiovascular relevance in chronic kidney disease patients. Anal Bioanal 
Chem. 2013;405(6):1937–47. 
30.  Ross AB. Present status and perspectives on the use of alkylresorcinols as biomarkers 
of wholegrain wheat and rye intake. J Nutr Metab. 2012;2012:462967.  
31.  Landberg R, Man P, Kamal-Eldin A. A rapid gas chromatography-mass spectrometry 
method for quantification of alkylresorcinols in human plasma. Anal Biochem. 
2009;385(1):7–12. 
32.  Landberg R, Marklund M, Kamal-Eldin A, Åman P. An update on alkylresorcinols – 
Occurrence, bioavailability, bioactivity and utility as biomarkers. J Funct Foods. 2013 
Oct 
33.  Marklund M, Landberg R, Aman P, Kamal-Eldin A. Determination of alkylresorcinol 
metabolites in human urine by gas chromatography-mass spectrometry. J Chromatogr 
B Analyt Technol Biomed Life Sci. 2010;878(11-12):888–94. 
34.  Zhu Y, Shurlknight KL, Chen X, Sang S. Identification and pharmacokinetics of novel 
alkylresorcinol metabolites in human urine, new candidate biomarkers for whole-grain 
wheat and rye intake. J Nutr. 2014;144(2):114–22.  
35.  Johansson-Persson A, Barri T, Ulmius M, Onning G, Dragsted LO. LC-QTOF/MS 
metabolomic profiles in human plasma after a 5-week high dietary fiber intake. Anal 
Bioanal Chem. 2013;405(14):4799–809. 
36.  Landberg R, Linko A-M, Kamal-Eldin A, Vessby B, Adlercreutz H, Aman P. Human 
plasma kinetics and relative bioavailability of alkylresorcinols after intake of rye bran. J 
Nutr. 2006;136(11):2760–5.  
37.  Van Dorsten FA, Grün CH, van Velzen EJJ, Jacobs DM, Draijer R, van Duynhoven 
JPM. The metabolic fate of red wine and grape juice polyphenols in humans assessed 
by metabolomics. Mol Nutr Food Res. 2010;54(7):897–908.  
38.  Mulder TP, Rietveld AG, van Amelsvoort JM. Consumption of both black tea and green 
tea results in an increase in the excretion of hippuric acid into urine. Am J Clin Nutr. 
2005;81(1 Suppl):256S–260S. 
39.  Valentova K, Stejskal D, Bednar P, Vostalova J, Cíhalík C, Vecerova R, et al. 
Biosafety, antioxidant status, and metabolites in urine after consumption of dried 
cranberry juice in healthy women: a pilot double-blind placebo-controlled trial. J Agric 
Food Chem. 2007;55(8):3217–24. 
40.  Jin Y, Alimbetov D, George T, Gordon MH, Lovegrove JA. A randomised trial to 
investigate the effects of acute consumption of a blackcurrant juice drink on markers of 
vascular reactivity and bioavailability of anthocyanins in human subjects. Eur J Clin 
Nutr. 2011;65(7):849–56. 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
94 
41.  Krupp D, Doberstein N, Shi L, Remer T. Hippuric acid in 24-hour urine collections is a 
potential biomarker for fruit and vegetable consumption in healthy children and 
adolescents. J Nutr. 2012;142(7):1314–20. 
42.  Henning SM, Wang P, Abgaryan N, Vicinanza R, de Oliveira DM, Zhang Y, et al. 
Phenolic acid concentrations in plasma and urine from men consuming green or black 
tea and potential chemopreventive properties for colon cancer. Mol Nutr Food Res. 
2013;57(3):483–93. 
43.  Nurmi T, Mursu J, Heinonen M, Nurmi A, Hiltunen R, Voutilainen S. Metabolism of 
berry anthocyanins to phenolic acids in humans. J Agric Food Chem. 
2009;57(6):2274–81.  
44.  Del Bo’ C,  iso P, Brambilla A, Gardana C,  izzolo A, Simonetti P, et al. Blanching 
improves anthocyanin absorption from highbush blueberry ( Vaccinium corymbosum 
L.) purée in healthy human volunteers: a pilot study. J Agric Food Chem. 
2012;60(36):9298–304. 
45.  Bondia-Pons I, Barri T, Hanhineva K, Juntunen K, Dragsted LO, Mykkänen H, et al. 
UPLC-QTOF/MS metabolic profiling unveils urinary changes in humans after a whole 
grain rye versus refined wheat bread intervention. Mol Nutr Food Res. 
2013;57(3):412–22. 
46.  Pekkinen J, Rosa NN, Savolainen O-I, Keski-Rahkonen P, Mykkänen H, Poutanen K, 
et al. Disintegration of wheat aleurone structure has an impact on the bioavailability of 
phenolic compounds and other phytochemicals as evidenced by altered urinary 
metabolite profile of diet-induced obese mice. Nutr Metab (Lond). 2014;11(1):1. 
47.  Altorf-van der Kuil W, Brink EJ, Boetje M, Siebelink E, Bijlsma S, Engberink MF, et al. 
Identification of biomarkers for intake of protein from meat, dairy products and grains: a 
controlled dietary intervention study. Br J Nutr. 2013;110(5):810–22. 
48.  Bondia-Pons I, Nordlund E, Mattila I, Katina K, Aura A-M, Kolehmainen M, et al. 
Postprandial differences in the plasma metabolome of healthy Finnish subjects after 
intake of a sourdough fermented endosperm rye bread versus white wheat bread. Nutr 
J. 2011;10:116. 
49.  Ross AB, Zangger A, Guiraud SP. Cereal foods are the major source of betaine in the 
Western diet--analysis of betaine and free choline in cereal foods and updated 
assessments of betaine intake. Food Chem. 2014;145:859–65. 
50.  Moazzami AA, Bondia-Pons I, Hanhineva K, Juntunen K, Antl N, Poutanen K, et al. 
Metabolomics reveals the metabolic shifts following an intervention with rye bread in 
postmenopausal women--a randomized control trial. Nutr J. 2012;11:88. 
51.  Moazzami AA, Zhang J-X, Kamal-Eldin A, Aman P, Hallmans G, Johansson J-E, et al. 
Nuclear magnetic resonance-based metabolomics enable detection of the effects of a 
whole grain rye and rye bran diet on the metabolic profile of plasma in prostate cancer 
patients. J Nutr. 2011;141(12):2126–32.  
52.  Ross AB, Bruce SJ, Blondel-Lubrano A, Oguey-Araymon S, Beaumont M, Bourgeois 
A, et al. A whole-grain cereal-rich diet increases plasma betaine, and tends to 
decrease total and LDL-cholesterol compared with a refined-grain diet in healthy 
subjects. Br J Nutr. 2011;105(10):1492–502.  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
95 
53.  Price RK, Keaveney EM, Hamill LL, Wallace JMW, Ward M, Ueland PM, et al. 
Consumption of wheat aleurone-rich foods increases fasting plasma betaine and 
modestly decreases fasting homocysteine and LDL-cholesterol in adults. J Nutr. 
2010;140(12):2153–7. 
54.  Servillo L, Giovane A, Balestrieri ML, Ferrari G, Cautela D, Castaldo D. Occurrence of 
pipecolic acid and pipecolic acid betaine (homostachydrine) in Citrus genus plants. J 
Agric Food Chem. 2012;60(1):315–21. 
55.  Struys EA, Jakobs C. Metabolism of lysine in alpha-aminoadipic semialdehyde 
dehydrogenase-deficient fibroblasts: evidence for an alternative pathway of pipecolic 
acid formation. FEBS Lett. 2010;584(1):181–6.  
56.  Pekkinen J, Olli K, Huotari A, Tiihonen K, Keski-Rahkonen P, Lehtonen M, et al. 
Betaine supplementation causes increase in carnitine metabolites in the muscle and 
liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics 
approach. Mol Nutr Food Res. 2013;57(11):1959–68.  
 
  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
96 
7. LEGENDS FOR FIGURES 
Figure 1. Partial least-squares discriminant analysis of the RP negative 
mode data. A: Score plot showing the individual end-point samples. Healthy 
Diet (black circle); Whole Grain Enriched Diet (gray square); Control (light 
grey triangle). B: Loading scatter plot showing the individual compounds. 
The depicted metabolites are: 1. Pyrocatechol sulfate, VIP 2.56; 2. CMPF, 
VIP 1.93; 3. Ar C21:1-Gln, VIP 1.79; 4. Hippuric acid, VIP 2.46; 5. Unknown, 
MW 188.094, rt 3.3, VIP 1.81; 6. Unknown lipid, MW 869.539, rt 11.8, VIP 
1.76. VIP: Variable influence on projection, MW: molecular weight. 
Figure 2. K-means cluster analysis with hierarchical clustering of the fold 
change values (beginning versus end of the intervention) for all study 
participants. Included are metabolic features having pcorr <0.05 in the RP 
ESI(-) data. The clusters are numbered one to seven as depicted in the 
figure. The color scale indicates fold change (fc) values between 0.12 and 
2.1. Gray color in the heat map indicates not detected value.  
Figure 3. Plots of peak areas of putative biomarkers as a function of 
reported consumption of selected foods in the Healthy Diet (black circle), 
Whole Grain Enriched Diet (dark grey square) and Control (light grey 
triangle) groups. A) Alkylresorcinol C21:1-Gly (AR C21:1-Gly) and the 
consumption of whole grain bread (at least 50 % of whole grain), B) Hippuric 
acid and the consumption of berries (includes whole berries, berry purées 
and berry juices). Three outliers in the Whole Grain Enrichment Diet group 
were excluded since their berry consumption included mainly juices with low 
polyphenol content and was more than two standard deviations away from 
the mean consumption of berries. C)  3-carboxy-4-methyl-5-propyl-2-
furanpropanoic acid (CMPF) and the consumption of fish. 
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Table 1. Annotated metabolites having p<0.05 in HD or WGED groups. Parameters for the LC-MS 
analysis include the chromatography (LC column), ionization mode in the mass spectrometry (MS 
mode), metabolite mass, identified ion (m/z) and retention time (Rt). The fold change values indicate 
the average fold change when compared against the control group, with p-values and FDR 
corrected p-values (n=106). 
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Table 2. Associations between plasma CMPF and dietary intake (n=104-105) 
Dietary intake CMPF 
 Baseline 
1
  End
2 
 Change
2
  
 r p-value Beta p-value Beta p-value 
All fish 0.254 0.009 0.472 6x10
-7
 0.337 4x10
-5
 
Fatty fish  0.228 0.190 0.448 2x10
-5
 0.280 0.001 
Lean fish 
3 
0.098 0.317 0.159 0.074 0.112 0.116 
Whole grain products 
 
0.154 0.118 0.102 0.506 -0.197 0.047 
Other grain products -0.061 0.538 -0.179 0.200 0.166 0.094 
Vegetables and root 
vegetables 
0.135 0.169 0.069 0.437 -0.042 0.602 
Fruits 
4 
0.059 0.548 0.081 0.348 -0.210 0.019
 
Berries 
4 
0.291 0.003 0.363 0.001 0.063 0.505 
Milk products -0.020 0.843 -0.078 0.360 0.078 0.343 
Red meat -0.048 0.629 0.089 0.307 -0.112 0.199 
Poultry  0.099 0.314 -0.122 0.158 0.039 0.473 
Potatoes -0.052 0.597 -0.081 0.345 0.016 0.849 
Nuts -0.070 0.477 -0.064 0.454 0.060 0.457 
Eggs -0.038 0.699 -0.006 0.994 0.045 0.582 
Vegetable oils and spreads 0.019 0.848 -0.056 0.519 -0.007 0.927 
Dairy fat based spread -0.056 0.572 -0.055 0.519 0.056 0.489 
1
Spearman Rank Correlation, 
2
 analysis of covariance (ANCOVA), intervention group included 
into the model, 
3
consumption was low, 
4
includes whole fruits/berries, purée and juice.  
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Table 3.  Associations between plasma CMPF and markers of fish intake (n=104-106) 
  CMPF 
 Baseline
1 
End
2 
Change 
2 
 r p-value Beta p-value Beta p-value 
Calculated dietary EPA 
intake
3 
0.273 0.005 0.423 3x10
-5 
0.188 0.058 
Calculated dietary DHA 
intake
3
  
0.254 0.009 0.389 1x10
-4 
0.314 2x10
-4 
Plasma EPA
4 
0.684 6x10
-16 
0.376 1x10
-5 
0.328 1x10
-4 
Plasma DHA
4 
0.665 8x10
-15 
0.363 2x10
-5
 0.232 0.006 
1
Spearman Rank Correlation, 
2
 analysis of covariance (ANCOVA), intervention group included into the model, 
3
calculated from food records, 
4
peak area in LC-MS analysis. 
Table 4. Correlation
1
 between changes in metabolites and changes in food intake (n=103-105).  
CHANGE   Intake of whole 
grain bread 
2,3
 
Intake of 
berries
3 
Intake of fish
3 
Metabolites mass retention time r p r p r p 
Hippuric acid 179.0580 3.14 RP(+) 0.026 0.797 0.380 7 x 10-5 0.119 0.228 
AR C21:1-Gln 578.3816 10.90 RP(-) 0.627 1 x 10-12 0.223 0.023 0.119 0.226 
AR C19:0-Gln 552.3660 10.85 RP(-) 0.474 4 x 10-7 0.174 0.077 0.093 0.347 
Pipecolic acid 
betaine 
157.1104 2.95 HILIC(+) 0.343 4x10-4 0.138 0.164 -0.007 0.942 
γ-butyrobetaine 145.1106 3.10 HILIC(+) 0.208 0.035 0.033 0.743 0.086 0.382 
Proline betaine 
analogue 
143.0945 3.95 HILIC(+) 0.275 0.005 -0.059 0.554 -0.012 0.901 
1
Spearman rank correlation, 
2 
at least 50 % whole grain,
 3
Changes in dietary intake are based on 4-day food 
records, which were kept at study weeks 0, 3, 7 and 11.
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Figure 1. Partial least-squares discriminant analysis of the RP negative mode data. 
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Figure 2. K-means cluster analysis with hierarchical clustering of the fold change values (beginning 
versus end of the intervention) for all study participants. 
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Figure 3. Plots of peak areas of putative biomarkers as a functional of reported consumption of 
selected foods in the HD (black circle), WGED (dark greq squares) and Control (light grey 
triangle) groups. 
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Supplemental Table 1. Clinical characteristics and the intake of energy and the most relevant 
nutrients (mean ± SD). 
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Supplemental Table 2. Metabolic features with FDR corrected p<0.05 in at least one of the test 
groups (HD, Healthy Diet;  WGED, Whole grain enriched Diet). 
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Supplemental Table 3. MS/MS fragmentation data for all of the identified metabolites. 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
109 
 
 
*I
d
e
n
ti
fi
c
a
ti
o
n
 i
s
 b
a
s
e
d
 o
n
 m
a
n
u
a
l 
M
S
/M
S
 s
p
e
c
tr
a
l 
in
te
rp
re
ta
ti
o
n
, 
M
e
tl
in
 I
D
 w
h
e
n
 M
S
M
S
 s
p
e
c
tr
u
m
 a
v
a
ila
b
le
, 
 o
r 
c
o
m
m
e
rc
ia
l 
s
ta
n
d
a
rd
 c
o
m
p
o
u
n
d
. 
S
e
rv
ill
o
 e
t 
a
l.
, 
2
0
1
2
, 
O
c
c
u
rr
e
n
c
e
 o
f 
p
ip
e
c
o
lic
 a
c
id
 a
n
d
 p
ip
e
c
o
lic
 a
c
id
 b
e
ta
in
e
 (
h
o
m
o
s
ta
c
h
y
d
ri
n
e
) 
in
 C
it
ru
s
 g
e
n
u
s
 p
la
n
ts
. 
J
. 
A
g
ri
c
. 
F
o
o
d
 C
h
e
m
. 
6
0
:3
1
5
-3
2
1
. 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
110 
Supplemental Figure 1. Participants Flow chart. 
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Supplemental Figure 2. LC-qTOF-MS/MS fragmentation of two alk(en)ylresorcinol 
glucuronides.  
 
 
The first neutral loss 176 refers to glucuronide unit. The peaks m/z 175.0241 and m/z 113.0233 
result from the deprotonated glucuronide unit. The aglycon ion gives molecular formula of 
C25H44O2, which matches with Nonadecyl-1,3-benzenediol, i.e. alkylresorcinol with C19:0 tail 
unit. Analysis with higher collision energy (CID 40eV) shows further fragmentation with neutral 
loss of 42 amu, which is visible twice: m/z 375.3261 to m/z 333.3145, and m/z 283.941 to m/z 
242.3127 referring to shortening of the tail by two carbon-units. The minor fragments include 
m/z 122.035 and m/z 81.0306, which have been detected in the LC-MS(-) analysis of intact 
alkylresorcinol C19:0 earlier (Dr. Alastair Ross, personal communication) (1, 2). 
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The neutral loss of glucuronide was observed for the molecule m/z 577.3737. The aglycon ion 
gives Metlin hit to 5-(16-Heneicosenyl)-1,3-benzenedion – an alkylresorcinol with the C21:1 
configuration in the carbon tail. The fragmentation pattern of the aglycon follows essentially the 
one seen for m/z 551.3600, with numerous smaller fragments in the region 60 to 130 amu (1, 
2). 
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ABSTRACT 
Background: The effects of olive oil phenolic compounds (PC) on the 
complex structure of high-density lipoprotein (HDL)-proteome, with respect 
to new aspects of cardioprotective properties, are still unknown. The aim of 
the current study was to assess the impact on the HDL protein cargo of the 
intake of virgin olive oil (VOO) and two functional VOOs, enriched with their 
own PC (FVOO) or complemented with thyme PC (FVOOT), in 
hypercholesterolemic subjects.  
Methods and Results: The VOHF study is a double blind, randomized, 
cross-over trial in which HDL fractions were obtained from 33 
hypercholesterolemic subjects who received for 3 weeks 25 mL/day of: 
VOO, FVOO, and FVOOT. Using a quantitative proteomics approach, based 
on iTRAQ-OFFGEL-LC-MS/MS analysis, 127 HDL-associated proteins were 
identified. Among these, 15 were commonly differently expressed after the 
three VOO interventions compared to baseline, with specific changes 
observed for each intervention.  Ingenuity pathway analysis revealed that the 
overlapping proteins, with cardioprotective functions, among the 
interventions were involved in the following pathways: LXR/RXR activation, 
acute phase response, atherosclerosis, IL-12 and production in 
macrophages, production of nitric oxide and reactive oxygen species in 
macrophages, clathrin-mediated endocytosis, and coagulation system. 
Conclusions: Consumption of VOO, or phenol-enriched VOOs, has an 
impact on the HDL proteome in a cardioprotective mode by up-regulating 
proteins related to cholesterol homeostasis, protection against oxidation and 
blood coagulation while down-regulating proteins implicated in acute-phase 
response, lipid transport, and immune response. The common observed 
protein expression modifications after the three VOOs indicate a major 
matrix effect. 
Clinical Trial Registration: ISRCTN77500181.  
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INTRODUCTION 
Phenolic compounds (PC) are versatile, heterogeneous, bioactive 
compounds naturally distributed in a number of edible plant products 
including fruit, vegetables, nuts, olive oil (OO), wine, tea, cocoa, and coffee. 
Epidemiologic studies suggest that a high dietary intake of PC is associated 
with beneficial effects on human health and provides protection against a 
number of chronic conditions including neurodegenerative and 
cardiovascular diseases (CVD), and some cancers
1–3
. Most of these PC 
health effects have been attributed to their antioxidant and radical 
scavenging activities, signaling cascade modifications, transcriptional 
networks
2
, and gene expression coding of key metabolic proteins
1,4
. OO is a 
food item typical of the Mediterranean diet, and several studies have 
revealed that it has a unique phenolic profile with specific biological 
properties. Results from the European EUROLIVE study
5
 showed that an 
increase in plasma high-density lipoprotein (HDL) cholesterol, and a 
decrease of low-density lipoprotein (LDL) oxidation, took place in a direct 
relationship with the PC content of the OO administered. These findings 
provided evidence to recommend the use of phenol-rich OO, i.e. virgin olive 
oil (VOO), in order to achieve beneficial effects. To date, studies have been 
focused on hydroxytyrosol because it has been reported as being the most 
biologically active PC in OO
6
. In fact, the European Food Safety Authority 
(EFSA) has recently released a health claim concerning the protective 
effects of the ingestion of PC from OO on lipid oxidative damage. The EFSA 
panel considers that the claim may be used only for OO which contains at 
least 5mg of hydroxytyrosol and its derivatives per 20g of OO. Thus, 20g of 
OO should be consumed daily in order to confer protection to LDL particles 
from oxidative damage
6
.  As the phenolic concentration  in most of the VOOs 
available on the market is too low to provide this daily amount,  the 
enrichment of VOO with its own PC could be a possible approach to assure 
and standardize the consumption without increasing caloric intake
7,8
. 
Furthermore, the enrichment of VOOs with hydroxytyrosol derivatives 
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combined with complementary phenols from aromatic herbs, such as thyme 
used for oil flavoring, might be  a good strategy to provide the optimum 
balance amongst the different kinds of OO PC such as flavonoids, 
monoterpens, and phenolic acids
9
. 
As previously mentioned, several of the beneficial effects of the OO PC have 
been linked to a lipid profile improvement and, more specifically, to the HDL 
molecule. HDL has traditionally been recognized as playing a central role in 
cholesterol reverse transport to the liver. In concrete, the efflux of cholesterol 
from peripheral tissues promoted by HDL is considered to be its main anti-
atherosclerotic function. In this context,  Farràs M, et al. (2013)
10
  have 
described the key role of OO PC in the up-regulation of genes involved in 
the cholesterol efflux from cells to HDL in humans.  In addition to cholesterol 
efflux, more novel biological and atheroprotective activities are currently 
being ascribed to the HDL particle, in particular to its protein cargo. 
Approximately one hundred different proteins, not considered to be 
apolipoproteins (APO), have been identified as being associated with the 
HDL particle
11
 and linked to its cardioprotective properties. These include  
the antioxidant, anti-inflammatory, antithrombotic, complement system 
regulation and protective effects on vascular endothelium and smooth 
muscle cells
12,13
. Such new data promise to better elucidate the relationship 
of HDL with atherosclerosis and contribute to the development of biomarkers 
of HDL functionality
14
. The considerable number of proteins and functions 
identified within the HDL proteome suggest that mere determination of HDL 
cholesterol, which is the current clinical marker related with HDL mass, 
probably do not provide accurate information about HDL functionality. 
Analysis of the HDL protein cargo is, however, still in its early stages, and 
data concerning the HDL proteome as a biomarker for disease or 
functionality are limited. Moreover, studies with respect to the impact of 
dietary interventions on the HDL proteome are scarce
15
 , and the effects of 
OO PC on the complex structure of the HDL protein cargo have not yet been 
evaluated.  
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
121 
In this context, we hypothesized that sustained consumption of PC from 
VOO, or functional phenol-enriched VOO, could modify the HDL proteome, 
which in turn could be related to their cardioprotective benefits. The objective 
of the current study was to assess the impact on the HDL protein cargo of a 
dietary intervention supplemented with a VOO or two different functional 
VOOs enriched with their own PC (hydroxytyrosol derivatives) or 
complemented with thyme PC (flavonoids, monoterpens, and phenolic 
acids), in hypercholesterolemic subjects from the VOHF study.  
METHODS 
Subjects and Study design 
The VOHF study aimed at assessing whether functional VOOs, enriched 
with their own PC or with them plus complementary phenols from thyme, 
could have a nutraceutical effect on HDL lipoprotein functionality. The 
present clinical trial was conducted in accordance with the Helsinki 
Declaration and the Good Clinical Practice for Trials on Medical Products in 
the European Community. All participants provided written informed consent, 
and the local institutional ethics committees approved the protocol (CEIC-
IMAS 2009/3347/I) registered with the International Standard Randomized 
Controlled Trial register (www.controlled-trials.com; ISRCTN77500181). 
The VOHF study was a randomized, controlled, double-blind, crossover 
clinical trial with 33 hypercholesterolemic volunteers (total cholesterol>200 
mg/dL; 19 men and 14 women), aged 35 to 80 year. Exclusion criteria 
included the following: BMI >35 Kg/m
2
, smokers, athletes with high physical 
activity (>3000 Kcal/day), diabetes, multiple allergies, intestinal diseases, or 
any other disease or condition that could worsen compliance. The study was 
conducted at IMIM- Hospital del Mar Medical Research Institute (Spain) from 
April 2012 to September 2012. The participants’ flow chart is described in 
Supplemental Figure 1.  
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Subjects were randomly allocated to one of 3 sequences of administration of 
25 mL/day of raw: a) VOO; 80 mg of PC/kg oil, b) functional VOO enriched 
with its own PC (FVOO; 500 mg of PC/kg oil), and c) functional VOO 
enriched with its own PC plus complementary phenols from thyme (FVOOT; 
500 mg of PC/kg; 50% of OO PC and 50% of thyme PC) (Sequence 1: 
FVOO, FVOOT and VOO, Sequence 2: FVOOT, VOO and FVOO, 
Sequence 3: VOO, FVOO and FVOOT) (Figure 1). The random allocation 
sequence was generated by a statistician, participant enrolment was carried 
out by a researcher, and participants’ assignment to interventions according 
to the random sequence was done by a physician. Due to the fact that all 
participants received each one of the three VOOs, restrictions such as 
blocking were unnecessary. Intervention periods were of 3 weeks and VOOs 
were consumed daily distributed among meals. There was a 2-week 
washout period prior to VOO interventions during which a common OO was 
consumed. To avoid an excessive intake of PC, the participants were 
advised to limit their consumption of polyphenol-rich foods during the clinical 
trial. A set of portable containers with the corresponding 25 mL of OO for 
each day of consumption were delivered to the participants at the beginning 
of each OO administration period. The participants were instructed to return 
the containers to the center after the corresponding OO consumption period 
in order to register the amount consumed. 
The procedure to obtain the phenolic extracts and the enriched oils has been 
previously described
9
. Supplemental Table 1 shows the phenolic 
compounds, the fat soluble micronutrients and the fatty acids daily intake 
with 25mL of VOO, FVOO, and FVOOT. 
Sample size and power analysis 
A sample size of 30 individuals allows a power of at least 80% to detect a 
statistically significant difference among groups of 3 mg/dL of HDL 
cholesterol, assuming a dropout rate of 15% and a Type I error of 0.05 (2-
sided).  
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Collection of blood samples 
Fasting blood samples were taken from 33 participants before the first 
washout period (first visit-baseline) and after each VOO intervention period 
(visits 3, 5, and 7), through a catheter in an antecubital vein (Figure 1). 
Blood was collected in Vacutainer® tubes with K2EDTA anticoagulant. Blood 
samples were centrifuged at 1 500 xg for 15 minutes and 2.8 mL of plasma 
were finally recovered. Protease Inhibitor Cocktail (PIC; Sigma-Aldrich, Tres 
Cantos, Spain) was added to plasma at a concentration 1/100 (1 µL of PIC 
for 100 µL of plasma). All samples were stored at -80ºC until processing. A 
total of 123 plasma samples were used for proteomic analyses (33 
participants per 4 visits minus 9 missing). See proteomic study flow chart 
(Figure 2). 
Human plasma HDL isolation 
The HDL fraction (d=1.036-1.21 g/mL) from each sample was isolated from 
2.5 mL of plasma by sequential density ultracentrifugation in two steps using 
sodium bromide (NaBr; Sigma-Aldrich, Tres Cantos, Spain), as previously 
described by Havel RJ, et al.
16
. Briefly, the VLDL, IDL, and LDL, were 
removed by ultracentrifugation at 140 000 xg for 21 h at 10 ºC after 
adjustment of the plasma density to 1.063mg/mL with NaBr. The HDL 
fraction was obtained by adjusting the infranatant density to 1.21 mg/mL with 
NaBr prior to ultracentrifugation at 140 000 xg for 40 h at 10 ºC. 2 mL of HDL 
fraction were recovered and later stored at -80ºC. 
HDL biochemical characterization 
Apo A-I, Apo A-II, and Apo B-100 were determined in HDL fractions using 
routine clinical chemistry assays (Horiba, Montpellier, France) in an 
autoanalyzer Cobas-Mira Plus (Roche Diagnostic System, Madrid, Spain). 
Total protein was quantified in HDL fractions by the Bradford method 
(BioRad, Hercules, CA, USA). HDL fraction purity was assessed through the 
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measurement of Apo B-100, almost all samples exhibited concentrations 
below the limit of detection (2 mg/dL). 
Statistical analysis of biochemical data 
The Kolmogorov-Smirnov test was used to verify the distributions of the 
variables. A paired Student’s t-test was employed for the comparison of 
paired and normally distributed variables. Wilcoxon signed-rank test was 
used for the comparison of paired and non-normally distributed variables. 
The level of statistical significance was set at p < 0.05. All statistical 
analyses were performed with Statistical Package for the Social Sciences 
(SPSS) for Windows (20.0 version; IBM corp., Armonk, NY, USA). 
Proteomic sample preparation and quantitative analysis 
For the proteomics studies (detailed in Supplementary Data) the 123 
isolated HDL samples were reduced to ten pools: 1 from first visit- baseline, 
3 after third visit, 3 after fifth visit, and 3 after seventh visit (Figure 2). The 
pools were then dialyzed and delipidated by methanol/ diethyl ether 
extraction, followed by a trichloroacetic acid/acetone protein precipitation 
before an in-solution tryptic digestion. Samples were subjected to an iTRAQ 
labeling for quantitative analysis, the resulting labeled peptides were 
separated according to their isoelectric point on an OffGel fractionator. 
Finally, two aliquots of the sample were analyzed by nLC-MALDI MS/MS 
and nLC-ORBITRAP-ESI MS/MS (Figure 2). The files generated with the 
two mass spectrometers were combined in order to identify the HDL-
associated proteins. The final identified proteins were required to present 
more than one peptide-spectrum match (PSM), or to have a minimum 
confidence score > 30% and coverage > 10%, in order to ensure accuracy in 
the assignment of protein identifications. In addition, intracellular and cell 
surface proteins were removed as being possible contaminants. In order to 
identify the differentially expressed proteins after interventions with respect 
to first visit- baseline, only samples analyzed by nLC-ORBITRAP-ESI 
MS/MS were used due to the precision of this method. Relative expression 
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levels were calculated for each protein as a ratio by Proteome Discoverer; 
biological replicates from the three iTRAQ sequences were then combined in 
an Excel spreadsheet and the mean of the ratios of all proteins calculated. 
Proteins with a differential expression of at least 0.8-fold change, or 1.3-fold 
change relative to baseline, were considered differentially expressed. In 
addition, a cut-off inferior to 0.5, or superior to 1.5, was applied to establish 
the most relevant protein expression changes observed after each 
intervention, defined as stronger effects. A detailed description of the 
methods and analysis is provided in the online-only Data Supplement. 
Clustering and Pathway analysis 
Various bioinformatic tools were employed for the biological interpretation of 
the results. Proteins are referred to by their gene encode symbol. 
Hierarchical clustering of protein expression data to investigate overall 
similarities of the proteome samples and identify the main biological 
functions involved was performed in web-tool STRING 9.1 (http://string-db-
org). Ingenuity Pathway analysis (IPA; Ingenuity System Inc., Redwook, CA, 
USA, www.ingenuity.com) was used to analyze canonical pathways and 
protein networks involving the differentially expressed proteins for biological 
interpretation. Significance levels were assessed with Fisher’s exact tests 
(p<0.01). The differentially expressed proteins were overlaid with IPA-
curated canonical pathways to explore possible metabolic and cell signaling 
pathways that were over- or under-represented by the experimentally 
determined genes. Specifically, we analyzed the proteins that overlapped 
the three VOO interventions in order to investigate potential common OO PC 
mechanisms. In addition, possible connections between mapped genes 
were evaluated and graphical networks were algorithmically generated. 
Nodes representing genes and gene products were linked by biological 
relationships. Networks were ranked by a score that defines the probability 
of a collection of nodes being equal to or greater than the number in a 
network achieved by chance alone. 
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RESULTS 
Participants’ characteristics  
Table 1 summarizes the baseline characteristics of the study participants, 
significant differences were not observed among groups. The three VOOs 
were well tolerated by all participants and no adverse events were reported.  
Biochemical characterization of HDL  
Compared to baseline, significant increases in Apo A-I (p = 0.027; p = 0.021; 
p = 0.006, respectively), Apo A-II (p = 0.029; p = 0.019; p = 0.004, 
respectively) and total protein (p = 0.073; p = 0.045; p = 0.037, respectively) 
were observed after the VOO, FVOO, and FVOOT intervention periods. 
HDL Proteomic results 
Identification of HDL-associated proteins  
A total of 155 HDL-associated proteins were initially identified by applying 
shotgun proteomics using Maldi and Orbitrap MS/MS to HDL fractions 
isolated by ultracentrifugation. Data were subsequently screened to ensure 
protein identification accuracy and 28 possible false-positives removed. The 
final list of HDL-associated proteins was refined to 127 proteins 
(Supplemental Table 2). The majority (80/127) were consistent with well-
established HDL-associated proteins determined in at least 3 different MS 
studies
11
 and 32 had been previously identified by at least 1 MS study
11,17
. A 
total of 15 novel proteins were identified: Beta-Ala-His dipeptidase, BPI fold-
containing family B member 1, Carbonic anhydrase 6, CD209 antigen, CD44 
antigen, CD5 antigen-like, Ig heavy chain V-I region HG3, Ig lambda-1 chain 
C regions, Ig lambda-2 chain C regions, Ig lambda-7 chain C region, Indian 
hedgehog protein, Integrin alpha-2, Integrin beta-1, Multimerin-2, and 
Thymidine phosphorylase. Six well-established HDL-associated proteins 
were not detected: Apo O, Ceruloplasmin, Complement factor B, Inter alpha 
trypsin inhibitor 2, Plasma Kallikerein and Plasminogen
11
.  
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Quantitative analyses 
Compared to baseline values (first visit), the HDL protein cargoes of the 
differentially expressed proteins differed after the interventions according to 
the VOO received. The complete list of the proteins differentially expressed 
after each VOO intervention, and their principal biological functions, are 
shown in Supplemental Table 3. The proteins were associated with a broad 
range of biological functions, principally cholesterol homeostasis, lipid 
transport, acute-phase response, blood coagulation, immune response, 
protection against oxidation, and proteolysis. The proteins differently 
modulated after VOO, FVOO, and FVOOT interventions and associated with 
these main functions are represented in Figure 3. The overlapping among 
interventions indicates that 15 proteins were commonly up- or down-
regulated after the three VOO interventions. These proteins were: Serum 
paraxonase/lactonase 3 (PON3), Apo A-II, Apo A-I, Apo D, Retinol binding 
protein 4 (RBP4), Heparin cofactor 2 (SERPIND1), zinc-alpha-2-glycoprotein 
(AZGP1), alpha-2-antiplasmin (SERPINF2), alpha-2-HS-glycoprotein 
(AHSG), clusterin (CLU), alpha-2-macroglobulin (A2M), haptoglobin (HP), 
alpha-1-acid glycoprotein (ORM1), Beta-Ala-His dipeptidase (CNDP1), and 
Aminopeptidase N (ANPEP). A protein-protein interaction network was 
generated for the 15 common, differentially expressed proteins using 
database and web-tool STRING 9.1 (Supplemental Figure 2). The common 
up-regulated proteins were related to cholesterol homeostasis, blood 
coagulation and protection against oxidation; the common down-regulated 
proteins were implicated in acute-phase response, lipid transport, immune 
response, and proteolysis. All proteins except for ANPEP and CNDP1, which 
are involved in proteolysis, appeared in the center of the functional network 
intersection indicating their key role in protein interactions.  
In addition to these 15 commonly modulated proteins, other specific protein 
expression changes were observed after each VOO intervention. The 
stronger effects for each VOO were related to the following biological 
functions linked to atherosclerosis protection: transport, homeostasis 
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cholesterol, antioxidant protection, blood coagulation, innate immune 
response, acute phase, and cellular adhesion. A stronger protein expression 
change was observed after VOO intervention in the following 6 proteins: Apo 
C-I, Apo A-I, Cholesteryl ester transfer protein (CETP), PON3, histidine-rich 
glycoprotein (HRG), and Ig heavy chain V-I region HG3, which were up-
regulated while Ig lambda chain V-III region LOI was down-regulated. A 
stronger effect after FVOO was observed on 2 protein expression changes, 
PON3 and platelet basic protein (PBP) which were up-regulated. Finally, a 
stronger up-expression change was noticed after FVOOT in the following 7 
proteins: Apo A-I, Apo A-IV, Apo C-II, Apo C-III, serum amyloid A protein 4 
(SAA4), afamin (AFM) and integrin beta-3 (ITGB3). 
Clustering and Pathway Analysis 
IPA analysis was performed to reveal the canonical pathways significantly 
affected (p<0.01) by OO phenols. The top 7 signaling pathways modified by 
the differentially expressed common proteins after all VOO interventions 
included: LXR/RXR activation, acute phase response signaling, 
atherosclerosis signaling, IL-12 signaling and production in macrophages, 
production of nitric oxide (NO) and reactive oxygen species (ROS) in 
macrophages, Clathrin-mediated endocytosis signaling, and coagulation 
system (Figure 4). Our results showed that OO phenols tended to have a 
strong effect on LXR/RXR activation (p=2.39E-16; ratio=0.071), followed by 
acute phase response signaling (p=4.91E-15; ratio=0.052). The highest 
scoring associated network generated by IPA, and the differentially 
expressed proteins common for all VOO interventions, are shown in Figure 
5. The top scoring significantly associated network (score=30) included 12 
focused proteins and several associated genes, and was related to the 
following biological functions: lipid metabolism, small molecule biochemistry, 
and molecular transport. The nuclear receptor subfamily 5, group A, member 
2 (NR5A2) and interleukin 6 (IL-6) were associated genes appearing in this 
network and representing the significantly affected top upstream regulators 
(p<0.01). NR5A2, which is implicated in the canonical pathway of FXR/RXR 
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activation and the biological process of cholesterol homeostasis, was 
predicted from our results to be activated. Likewise, IL-6, which is involved in 
the acute phase response canonical pathway, was expected to be inhibited.  
DISCUSSION 
The present study revealed that, in hypercholesterolemic subjects, a 
supplementary consumption of 25 mL/day of raw VOO, FVOO, or FVOOT 
has an impact on the HDL proteome by changing the expression of a 
number of proteins with biological functions related to the cardioprotective 
function of the HDL particle. The greatest expression modifications were 
observed in 15 of the 127 proteins identified in the HDL fractions which were 
commonly up- or down- regulated after the three VOO interventions. A 
finding that encouraged us to highlight the effect of the fatty acid composition 
and the role of the PC of the common matrix of the three VOO tested on 
HDL remodeling. After the three VOO interventions, the commonly up-
regulated proteins were mainly related to the following biological functions: 
cholesterol homeostasis, blood coagulation, and protection against 
oxidation. Down-regulated ones were involved in acute-phase response, 
lipid transport, and immune response leading to a CVD protective HDL 
profile. Moreover, IPA analysis revealed that signaling pathway LXR/RXR 
activation, acute phase response signaling, atherosclerosis signaling, IL-12 
signaling and production in macrophages, production of NO and ROS in 
macrophages, Clathrin-mediated endocytosis signaling, and coagulation 
system were affected by OO PC consumption. These data emphasize the 
key role of OO PC in modifying pathways and conferring cardioprotective 
properties. To our knowledge, this is the first HDL proteomic study in 
humans that assesses the effects of OO PC on the HDL protein cargo. 
Common effects of VOO interventions  
Two well-known proteins related to cholesterol homeostasis, Apo A-I and 
Apo A-II, were significantly augmented after the three VOO interventions.  
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Both proteins participate in reverse cholesterol transport and present anti-
inflammatory and antioxidant properties
13,18
. Our results are reinforced by 
the fact that these increases were also observed in our biochemical 
characterization of HDL determined by autoanalyzer. The increase in Apo A-
I concurred with the results observed by Solà et al.
19
 in high CVD risk 
subjects after following a Mediterranean diet rich in VOO. 
Two proteins related to blood coagulation, SERPIND1 and A2M, were up-
regulated after the three VOO interventions thus increasing the 
cardioprotective activity of the HDL particle. SERPIND1 inactivates thrombin 
action in the subendothelial layer of the vascular wall whilst A2M inhibits 
proteinases regulating the extracellular proteolytic activity resulting from 
clotting and fibrinolysis
20,21
. 
PON3 was up-regulated after all VOO interventions. It is one of the three 3 
known genotypic forms of the paraoxonase family and very similar in activity 
to PON1 although it has been less studied 
22
. PON3 acts as an antioxidant 
inhibiting LDL oxidation and enhancing the capacity of the HDL particle to 
protect against oxidation. The effect of up-regulating PON3 could be 
indicative of an improvement in the oxidative status of the HDL particle 
promoted by the interventions. 
AHSG, ORM1, SERPINF2, and HP are acute-phase response proteins 
which were down-regulated after all VOO interventions. Acute-phase 
proteins are increased during inflammation and could be used as 
inflammatory biomarkers related to CVD
23,24
. Our results are in concordance 
with those of Santos-González et al.
25
 who observed a decrease in acute-
phase response proteins after a VOO diet in rats.  
Plasma Apo D is a component of HDL and is structurally similar to the 
lipocalins, a diverse family of lipid-binding proteins that are responsible for 
transporting lipids and other small hydrophobic molecules. RBP4, which also 
belongs to the lipocalin family, is an adipokine that delivers retinol from the  
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liver stores to the peripheral tissues. These two proteins, which have been 
reported to be up-regulated during CVD development
26,27
, decreased after 
the three  VOO interventions. 
CLU, or Apo J, is a component of the HDL particle which  participates  in 
diverse physiological processes such as the complement system, innate 
immune response, lipid transport, cholesterol efflux, apoptosis, oxidation, 
and inflammation
28
. It has been suggested that CLU might play a 
compensatory protective role by acting as an inflammatory modulator in 
myocardial infarction
29
 . In the same way, AZGP1, which is mainly related to 
immune response, lipid metabolic process, and anti-inflammatory effects 
acting as an adipokine
30
,  has been observed to be up-regulated to 
counteract metabolic stress situations in humans
30
. Both proteins were 
down-regulated after all VOO interventions. Our results concur with Santos-
González et al.
25
 who showed down-regulated levels of CLU after a VOO 
diet in rats. 
Stronger effects of each VOO intervention 
In addition to the commonly modulated proteins, specific strong effects on 
the HDL protein cargo were also observed after each intervention.  For 
instance, after the intervention with VOO, Apo C-I, Apo A-I, CETP, and 
PON3 were markedly up-regulated. Among these changes the up-regulation 
of CETP is noteworthy. This protein facilitates the transport of cholesteryl 
ester from HDL to Apo B-100 containing lipoproteins, and its plasma activity 
has been suggested to be inhibited after a PC intervention 
31
. To our 
knowledge, data concerning the effects of PC on the expression and activity 
of CETP directly determined in HDL samples instead of plasma samples are 
limited.  Our results should be complemented with further studies assessing 
the activity and functionality of this enzyme in HDL in order to determine 
whether the observed expression changes are relevant for the biological 
processes involved. In addition, a major increase in histidine-rich 
glycoprotein (HRG), which plays a role in modulating coagulation, innate 
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immunity, and inflammation, was detected after VOO
32
. Changes in some 
immunoglobulins after VOO intervention were also reported. 
Immunoglobulins, which are secreted proteins related to innate immune 
response, could be plasmatic contaminants and, as a result,  several HDL 
proteomic studies have discarded them as being HDL-associated
17
. The 
literature with respect to their functioning as HDL-associated proteins is, 
however, scarce. Nevertheless, the possibility that the HDL particle could act 
as a transporter of these proteins cannot be discarded and their role should 
be further studied.  
From all the marked expression changes observed after the FVOO 
intervention, we would like to emphasize the up-regulation of the PON3 and 
platelet basic protein (PBP). Up-regulation of PON3 has also been described 
as a major effect after VOO and further studies are needed in order to 
determine the activity and functionality of this enzyme in HDL. PBP is a 
small platelet-derived cytokine that is released from activated platelets and is 
related to platelet activation and immune response, which could be of 
interest in atherosclerosis research.  
We also highlight the strong up-regulation of Apo A-I, Apo A-IV, Apo C-II, 
and Apo C-III among the changes observed after the FVOOT intervention. 
Apo A-IV is mainly related to cholesterol homeostasis and oxidative 
protection, and has been associated with the cardioprotective properties of 
the HDL particle
33
.  Although Apo C-III protein is present in HDL, it is also a 
major protein in VLDL. Chang et al.
34
 showed positive associations between 
HDL- Apo C-III and the presence of CVD, suggesting that high levels of Apo 
C-III in the HDL particle may represent a class of dysfunctional HDL. Such 
results are, however, still controversial. A redistribution of APOs between 
proatherogenic lipoproteins such as LDL to cardioprotective HDL could have 
been possible during the FVOOT intervention. We also observed a relevant 
increase in Serum amyloid A protein 4 (SAA4) which is an acute-phase 
response protein and a biomarker of inflammatory response associated with 
atherosclerosis
35,36
. Controversially, it has been suggested that SAA proteins  
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might exert an atheroprotective function during acute-phase response by 
improving HDL cholesterol efflux activity from macrophages
37
. Further 
studies focused on the effects of phenol-enriched VOO intake on the HDL 
functionality are needed. Other observed changes were the clear increase in 
afamin (AFM) and integrin beta-3 (ITGB3) proteins after the FVOOT 
intervention. Afamin, which is related to vitamin E transport
38
, has been 
identified in several HLD proteomic studies and suggested as being a well-
established HDL-associated protein
11
. Integrin beta-3, which plays a critical 
role in platelet aggregation and normal hemostasis
39
, has been identified in 
only a few HDL proteomic studies
13
 and data concerning its presence and 
function in the HDL particle are limited.  
Limitations and strengths 
One of the strengths of this study is its randomized and crossover design, 
which permitted the participants to ingest all olive oils types. In this 
proteomic analysis a pooling sample approach was employed in order to 
focus primarily on the whole protein response and also to optimize the 
associated research expenses.  HDL isolation is a key methodological point 
for proteomic studies. Whilst sequential ultracentrifugation may alter HDL 
functionality, composition, and lead to a loss of lipid-poor Apo A-I  it 
continues to be the most commonly used procedure in these studies
40
. 
Moreover, the possibility exists that non-HDL plasmatic contaminants could 
have been present in the isolated HDL fraction. We identified HDL-
associated proteins with two different MS techniques, Orbitrap and Maldi, 
which provide reliability and robustness to our identification results.  
In conclusion, consumption of VOO, or phenol-enriched VOOs, has an 
impact on the HDL proteome in a cardioprotective mode that could enhance 
HDL functionality by up-regulating proteins related to cholesterol 
homeostasis, protection against oxidation, and blood coagulation while 
down-regulating proteins involved in acute-phase response, lipid transport, 
and immune response. The common protein expression modifications 
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reported after the three VOOs indicate an important effect of the fatty acid 
and PC composition present in the common matrix of these VOO on the 
HDL remodeling. Further studies are needed, however, in order to assess 
the specific effects of each VOO incorporating different phenolic contents. 
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FIGURES LEGEND 
Figure 1. Experimental protocol for the intervention study. VOO: Virgin 
Olive Oil; FVOO: Functional Virgin Olive Oil enriched with its own PC; 
FVOOT: Functional Virgin Olive Oil enriched with its own PC plus 
complementary phenols from thyme. Blood collection for proteomic analysis: 
Visit 1, baseline; Visit 3, post-first intervention; Visit 5, post-second 
intervention; Visit 7, post-third intervention. 
Figure 2. Proteomic study flow chart. S1: Sequence 1; S2: Sequence 2; 
S3: Sequence 3; HDL: High-density lipoprotein; P.: Pool; SCX: Strong 
Cation Exchange.  Visits with n lower than 11 was due to loss of participants 
for the following reasons: dropout, did not participate in all interventions, did 
all the interventions but not all the tests, or sample loss during laboratory 
processing.  
Figure 3. Venn diagram showing intersections of proteins differentially 
expressed after VOO, FVOO, and FVOOT interventions. Proteins are 
presented with their gene encode symbol. Red proteins: up-regulated; green 
proteins: down-regulated. VOO: Virgin Olive Oil; FVOO: Functional Virgin 
Olive Oil enriched with its own PC; FVOOT: Functional Virgin Olive Oil 
enriched with its own PC plus complementary phenols from thyme. 
Figure 4. The top 7 signaling pathways that were significantly affected 
by the 15 common proteins differentially expressed after all VOO 
interventions.  The pathways were ranked by p value. Blue bars indicate 
the negative log value (p-value). The ratio was calculated as the number of 
molecules in a given pathway that meet cutoff criteria divided by total 
number of molecules that make up that pathway. 
Figure 5. Top scored associated network generated by IPA describing 
common differentially expressed proteins after all VOO interventions. 
Proteins were presented with their gene encode symbol. The proteins 
indicated in red and green are those whose expression levels were 
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significantly up- or down-regulated, respectively. Proteins indicated in white 
are those available in the IPA database, but not detected as differentially 
expressed in the present study. The shapes of the symbols denote the 
molecular class of proteins. Solid lines indicate direct molecular interactions, 
whereas dashed lines indicate indirect molecular interactions. 
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Table 1. Characteristics of the study participants at baseline. 
Variable Sequence 1 (n=11) Sequence 2 (n=11) Sequence 3 (n=11) 
Gender (male/female) 5/6 7/4 7/4 
Age, years 54.91 ± 12.57 55.27 ± 11.88 55.45 ± 7.84 
Body weight, kg 74.75 ± 16.80 74.60 ± 18.49 84.45 ± 17.74 
BMI, kg/m2 25.63 ± 3.68 26.31 ±5.25 27.85 ± 4.71 
SBP, mm Hg 125.09 ± 18.70 128.27 ± 16.69 130.45 ± 17.93 
DBP, mm Hg 68.09 ± 13.53 72.27 ± 9.31 71.91 ± 13.43 
Glucose, mg/dL 88.55 ± 11.63 93.00 ± 13.33 90.91 ± 10.53 
Total cholesterol, mg/dL 228.36 ± 42.70 231.91 ± 32.70 218.82 ± 31.21 
LDL cholesterol, mg/dL 150.38 ± 32.33 152.08 ± 28.46 142.26 ± 25.72 
HDL cholesterol, mg/dL 52.78 ±11.75 52.96 ±12.82 53.39 ± 9.55 
Tryglicerides, mg/dL 94.00 (75.00; 149.00) 119.00 (95.00; 168.00) 117.00 (81.00; 126.00) 
Values expressed as mean ± standard deviation (SD) or median (25
th
 to 75
th
 percentile). 
Sequence 1= FVOO, FVOOT and VOO; Sequence 2= FVOOT, VOO and FVOO; Sequence 3= 
VOO, FVOO and FVOOT. Abbreviations: BMI, body mass index; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; LDL, low density lipoprotein; HDL, high-density lipoprotein. 
 
 
 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
BIOACTIVE FOOD COMPOUNDS OF MEDITERRANEAN AND NORDIC DIETS AND THEIR EFFECTS 
ON NUTRITIONAL AND CARDIOVASCULAR DISEASE. 
Anna Pedret Figuerola 
Dipòsit Legal: T 1916-2014
Methods and Results 
142 
Figure 1. Experimental protocol for the intervention study 
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Figure 2. Proteomic study flow chart 
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Figure 3. Venn diagram showing intersections of proteins differentially expressed after VOO, 
FVOO and FVOOT 
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Figure 4. The top 7 signalling pathways that were significantly affected by the 15 common 
proteins differentially expressed after all VOO interventions 
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Figure 5. Top scored associated network generated by IPA describing common differentially 
expressed proteins after all VOO interventions. 
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SUPPLEMENTAL MATERIAL 
SUPPLEMENTAL METHODS 
Proteomic sample preparation and analysis 
Pooling 
The 123 isolated HDL samples were divided into ten pools taking into 
consideration the randomized sequence detailed in Figure 1 and the visit 
number. Pool 1 includes the HDL fraction from visit 1 of all participants 
(n=33) in order to normalize the data obtained between the three groups 
(Figure 2). Protein pools were dialyzed using Amicon Ultra-4 10K filters 
(Millipore, Co. Cork, IRL) at 4 000 xg for 20 minutes at 4 ºC. 
HDL delipidation and protein precipitation 
After concentration, pools were delipidated and precipitated. Briefly, 
concentrated HDL samples were dripped over 3 mL of methanol (Sigma-
Aldrich, Tres Cantos, Spain) and then 7 mL of diethyl ether (-20°C; Sigma-
Aldrich, Tres Cantos, Spain) were added. Samples were incubated for 10 
minutes on ice, centrifuged at 1 000 rpm for 5 minutes at 4 °C, and 
supernatants were aspired. The step was repeated with 10 mL of diethyl 
ether (-20°C) and finally pelleted samples were suspended into 200 µL of 
sodium dodecyl sulfate- dithiothreitol (SDS-DTT) solution (62.5 mM Tris-HCl, 
2%, SDS, 40 mM DTT)  and stored at -80ºC. Samples were precipitated with 
trichloroacetic acid (TCA) (Sigma-Aldrich, Tres Cantos, Spain) and acetone 
(AppliChem GmbH , Darmstadt, Germany), to concentrate and purify them. 
The pellet was resuspended in dissolution buffer (0.5 M triethylammonium 
bicarbonate, pH 8.5 and 0.1% SDS). Total protein concentration was 
calculated by Bradford assay (Sigma, St Louis, MO, USA). 
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In-solution protein digestion  
50 µg of each sample was reduced for 1 h at 60 ºC with 5 mM tris-(2-
carboxyethyl)phosphine (TCEP) (Sigma-Aldrich, Tres Cantos, Spain) and 
alkylated for 30 min at room temperature in the dark with 4mM 
iodoacetamide (Sigma-Aldrich, Tres Cantos, Spain). Sequencing grade 
trypsin (Promega Corporation, Madison, USA) was added in a 1:100 (w/w) 
ratio and the incubation was carried out overnight at 48 °C. 
iTRAQ labeling 
Samples were labelled following the manufacturer's instructions of iTRAQ 4-
plex (Applied Biosystems, Foster City, CA, USA), using 3 separate 4-plex 
iTRAQ kits, one for each randomized sequence (Figure 2). Control (pool 1) 
was labeled with 114 tag, and the rest of the samples were labelled by 
alternating 115, 116, and 117 tags to avoid bias. The excess of iTRAQ 
reagents was removed using a strong cation exchange (SCX)-cartridge 
(Strata, Phenomenex, Torrence, CA, USA). Peptides were eluted with a 
volatile buffer containing 5% ammonia and 30% methanol and subsequently 
dried in SpeedVac system prior to OffGel electrophoresis (OGE) 
fractionation. 
OffGel fractionation  
The resulting labeled peptides were separated according to their isoelectric 
point using 24 cm IPG strips (pH 3-10) on an Agilent 3100 OFFGEL 
fractionator, the separated components were then recovered in liquid 
fractions.  The three sample sequences (three sets of iTRAQ labelling) we 
processed in parallel, diluting the dried mixtures in 1.8 ml of the focusing 
buffer containing only 5% (v/v) of glycerol contrary to the supplier’s protocol. 
IPG strips (24cm, pH 3-10) were rehydrated by adding 40 μl of peptide IPG 
strip rehydration solution per well for 15 minutes. Then, the dried peptide 
mixtures samples were dissolved directly in the peptide OFFGEL stock 
solution, pH 3-10 and 150 μl of sample were loaded in each well. Peptide 
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focusing was performed until it reached 50 kVh with a maximum voltage of 8 
000 V and maximum current of 50 μA. After focusing, the 24 liquid fractions 
were carefully recovered and well rinsed twice with 150 μl of 0.1% Formic 
Acid (FA) for 15 minutes, to recover the maximum sample solution for each 
well. 3x24 peptide fractions were finally obtained. 
All fractions were checked by MALDI-TOF, those with higher mass 
intensities were kept alone whilst fractions with similar or lower intensities 
were combined, resulting 10 different fractions for each set of iTRAQ 
labelling. Samples were desalted and purified using Sep-Pack 100 mg C18 
cartridge (Waters, Elstree, UK). The eluent was concentrated to dryness and 
reconstituted in 50 µL 0.1% FA.  
Nano-LC separation and MALDI MS/MS 
A 15 μl-aliquot of each fraction was analyzed by LC–MALDI-TOF/TOF. An 
Easy-nLC system (Proxeon, Thermo Scientific) coupled to a Proteinner-fc 
fraction collector (Bruker) was used for the nano-LC with a C18 pre-column 
(EASY-Column, 2 cm, ID100 µm, 5 µm, C18-A1) and a C18 analytical 
column (EASY-Column, 10cm, ID75µm, 3µm, C18-A2). Mobile phases were 
water (A) and acetonitrile (ACN) (B), both containing 0.1% (v/v) 
trifluoroacetic acid (TFA). Peptides were separated over 35 min at a flow 
rate of 0.3 μL/min as follows: 0−60% solvent B within 10 min; 10 min 100% 
solvent B; and held for 15 min 2% solvent B before ramping back down to 
the initial solvent conditions. During gradient, 16’’ fractions were collected 
and directly deposited on a Maldi Target plate PACII 384, pre-spotted with α-
cyano-4-hydroxycinnamic acid matrix. MALDI plates were rinsed with 10 mM 
ammonium phosphate monobasic buffer (Sigma-Aldrich, Tres Cantos, 
Spain) and immediately analyzed on a MALDI-TOF/TOF UltrafleXtrem 
(Bruker Daltonics, Bremen, Germany) instrument. Automated data 
acquisition was done using Flex Control v 3.4 and Warp-LC v 1.3 softwares ( 
Bruker) , and was constituted to a full scan (m/z 700-5000) in positive 
reflector ion mode using 2 000 laser shots for every MS spectra. The twenty 
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most abundant peptide precursor ions, with a signal-to-noise ratio greater 
than or equal to 10, were selected for MS/MS analysis with LIFT detection 
mode using 4 000 laser shots. 
Data analysis (MALDI) 
The raw data files for protein identification were processed using 
FlexAnalysis v 3.4 via ProteinScape v 3 softwares (Bruker). Searches were 
performed with Mascot v 2.4.0 (Matrix Science, London, UK), against the 
SwisProt (released on 03/2013) human database. The following search 
parameters were selected: Homo sapiens for organism, trypsin as the 
digestion enzyme, with up to 2 missed cleavages allowed, cysteine 
carbamidomethylation as a fixed modification, whilst oxidation of methionine 
was set as variable. Tolerance settings were 50 ppm for full scan and 0.9 for 
MS/MS. Protein identifications were accepted with a minimum peptide 
Mowse score of 10 and a minimum Protein Mascot Score of 20. 
Nano-LC separation and ORBITRAP MS/MS 
Samples were analyzed on an Orbitrap Velos PRO instrument (Thermo 
Fisher Scientific, Bremen) connected to an Easy-nLC system (Proxeon, 
Thermo Scientific) with the same configuration columns as the nLC for 
MALDI, but coupled to a nanoelectrospray source with a stainless steel 
emitter. Solvent A consisted of 0.1 % FA in deionized water (Milli-Q, 
Millipore), and solvent B consisted of 0.1 % FA in 100% ACN. The flow rate 
was 0.3 μL/min with a 130 min long separation gradient running from 5% to 
100% B. The mass spectrometry detection constituted a full scan (m/z 350–
2 000) with Orbitrap detection at resolution R=30,000 (at m/z 400) followed 
by up to ten data-dependent acquisition MS/MS scans with Orbitrap 
detection of the most intense ions. The signal threshold for triggering an 
MS/MS event was set to 10 000 counts. The low mass cutoff was set to 100 
m/z. Charge state screening was enabled, and precursors with unknown 
charge state or a charge state of 1 were excluded. Dynamic exclusion of 30  
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s was used with an activation time of 0.1 s. For efficient fragmentation and 
detection of iTRAQ reporter ions, HCD normalized collision energy of 45 was 
used since reported optimization experiments showed that it gave the 
highest number of identified peptides with iTRAQ signal. 
Data analyses (ORBITRAP) 
Peak lists were searched against Swissprot (released on 03/2013), 
taxonomy filter was set to Homo sapiens using Mascot software version 
2.4.04 (Matrix Science, UK). Proteome Discover v 1.4 was used for protein 
identification and iTRAQ reporter quantification. Trypsin was chosen as 
cleavage specificity with a maximum number of three missed cleavages 
allowed. Carbamidomethylation (C) was set as a fixed modification whereas 
those originating from iTRAQ protocol (iTRAQ4Plex on the N-terminal 
residue, iTRAQ4Plex on tyrosine (Y), iTRAQ4Plex on lysine (K)) and 
oxidation (M) were used as variable modifications. The searches were 
performed using a peptide tolerance of 7 ppm and a product ion tolerance of 
0.02 Da (Orbitrap readout).  For further filtering the decoy search options 
was enabled and only unique peptides were accepted. The resulting data 
files were exported and filtered for <1% false discovery rate at peptide. 
Hence there is no fixed Mascot score cutoff because peptide matches are 
accepted until a FDR rate of 1% is reached. However, only PSMs with 
Mascot scores >20 were accepted to ensure that only high quality data were 
employed for this study.  
The files generated with Maldi and Orbitrap MS/MS were combined in order 
to identify the HDL-associated proteins. The final identified proteins were 
required to present more than one peptide-spectrum match (PSM) or have a 
confidence score at least >30% and a coverage >10%.   
Quantification and statistics (ORBITRAP) 
Samples analyzed by nLC-ORBIRAP-ESI MS/MS were used for the 
quantitative analyzes. In the quantitative calculations, only protein isoforms 
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with iTRAQ values in at least two of the analyses were included. For each 
protein, the relative expression levels were calculated as a ratio between the 
sample and the 114 labeling controls. Biological replicates from the three 
iTRAQ sequences were combined in an Excel document where the mean of 
the ratios of each protein were calculated. Proteins identified as differentially 
expressed were those with a differential expression of at least 0.8-fold 
change, or 1.3-fold change relative to the baseline. In addition, a cut-off 
inferior to 0.5 or superior to 1.5 was applied to establish the more relevant 
protein expression changes observed after each intervention, which were 
defined as stronger effects. 
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Supplemental Table 1. Virgin olive oils composition. Phenolic compounds, fat soluble 
micronutrients and fatty acids daily intake through 25 mL of VOO, FVOO and FVOOT. 
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Supplemental Table 2. HDL-associated proteins identified by MALDI and ORBITRAP MS 
techniques. 
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Supplemental Table 3. Proteins differentially expressed after each VOO intervention. 
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SUPPLEMENTAL FIGURE LEGENDS 
Supplemental Figure 1. Participants Flow-chart based on post-interventions 
of HDL proteomics variables. Sequence 1: FVOO, FVOOT and VOO; 
Sequence 2: FVOOT, VOO and FVOO; Sequence 3: VOO, FVOO and 
FVOOT. 
Supplemental Figure 2. Protein-protein interaction network for the 15 
commonly differentially expressed proteins after the three VOO interventions 
(http:www.string-db.org). Proteins were presented with their gene encode 
symbol. Nodes represent genes encoding interacting proteins and the lines 
between them represent known and predicted interactions.  
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Supplemental Figure 1. Participants Flow-chart. 
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Supplemental Figure 2. Protein-protein interaction network for the 15 commonly differentially 
expressed proteins after the three VOO interventions (http:www.string-db.org). 
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The present work provides evidence that certain bioactive 
compounds of the Mediterranean and Nordic diets can be assessed and 
monitored by nutritional biomarkers, improving the accuracy of the dietary 
intake measure. Moreover, the Mediterranean and the Nordic dietary 
bioactive compounds have been associated with protective effects on the 
development of CVDs, in both healthy and CVD risk subjects. Thus, TPE 
was used as a biomarker of the TPI and for assessing the relation between 
polyphenol intake and oxidative stress biomarkers. By applying a LC-MS-
based non-targeted metabolite profiling approach, novel and more specific 
biomarkers of the consumption of certain foods were identified. Moreover, 
using an iTRAQ-LC-MS/MS quantitative proteomic approach, molecular 
biomarkers were identified and related to the mechanisms of action and 
healthy biological effects of the studied bioactive compound-rich foods on 
CVDs.  
In Study 1, we evaluated the effects of the TPI on oxidative stress, which is 
a known risk factor for developing CVDs (Li et al., 2013). This study was 
conducted in healthy subjects of different ages following a MD pattern. The 
TPI was assessed by the urinary TPE, which is a validated biomarker for the 
dietary intake of polyphenol-rich foods and which represents a first approach 
to study the TPI through nutritional biomarkers (Medina-Remón et al., 2009). 
Interestingly, the studied population had a wide age range from 18 to 72 
years, which enabled us to observe a significant increase in the TPE with 
age. This association could be related to an increase in the consumption of 
vegetables, fruits, and coffee and to a moderate intake of fermented 
beverages with age, which are the greatest contributors to the TPI in our 
population. Moreover, our results confirm that the urinary TPE is related to 
changes in oxidative stress biomarkers. We observed that individuals with a 
higher urinary TPE had lower levels of 8-OHdG in urine and of GSSG in 
erythrocytes, indicating an attenuation of oxidative damage and consequent 
protection regarding the development of CVDs (Valavanidis et al., 2009; 
Yang et al., 2011). We also observed that polyphenols from vegetables and 
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fermented beverages (red wine being the most significant) were more 
related to the decrease in urinary 8-OHdG. Some studies indicate that 
polyphenols might exert inductive or signaling effects, which mediate 
inflammatory and antioxidant signals (Hollman et al., 2011; Stevenson et al., 
2007). However, in this study, we did not study the specific role of 
polyphenols on particular signaling pathways to produce their protective 
effect against oxidative damage. The objective of this study was to assess 
the general relation between polyphenol-rich foods and oxidative stress 
biomarkers. To obtain this insight, we needed to determine the urinary TPE 
rather than individual polyphenols or nutritional biomarkers of particular 
polyphenol-rich foods. However, our results noted that there were 
associations between specific food groups and oxidative stress biomarkers; 
however, unfortunately, the urinary TPE biomarker did not allow the detailed 
effect of each polyphenol-rich food on oxidative protection to be 
differentiated. Therefore, we found an increasing need to study specific 
biomarkers for bioactive food compound intake and to explore the specific 
effects that these compounds exert on signaling pathways and the 
mechanisms of action involved. This new information would allow us to  
better understand how bioactive food compounds act and provide the 
observed health effects. To further achieve these new profiling objectives, 
Study 2 and Study 3 were conducted by applying omic technologies.  
In Study 2, we assessed the effect of two partially overlapping dietary 
modification interventions, with whole grain or with whole grain plus 
bilberries and fatty fish, on plasma metabolite profiles. In this study, we 
assessed the effect of a dietary intervention with bioactive foods typical of 
the healthy Nordic diet on a Finnish population with MetS. The healthy 
Nordic diet, as well as the MD, has been associated with beneficial effects 
on CVDs (Olsen et al., 2011). 
Through non-targeted metabolomic analyses, specific biomarkers for whole 
grain, bilberries and fatty fish intake were identified. In our study, the fasting 
plasma hippuric acid metabolite level correlated positively with the 
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consumption of bilberries, thus suggesting this metabolite as a novel 
biomarker for bilberry intake. In contrast, glucuronidated alk(en)ylresorcinols 
were identified for the first time in fasting human plasma, and we found a 
strong positive correlation between their changes in plasma levels and the 
consumption of whole grain, thus suggesting these molecules as new 
biomarkers for whole grain intake.  Finally, we identified CMPF furan fatty 
acid as a potential biomarker for fatty fish intake, and in our study, this fatty 
acid was a stronger biomarker for fish intake than the established 
biomarkers EPA and DHA. In addition to these potential biomarkers of food 
intake, we identified molecular biomarkers of endogenous metabolism that 
could explain the effect of the consumed bioactive compounds on metabolic 
pathways and, thus, explain their beneficial effects on CVD onset and 
progression. The plasma levels of several amino acids, such as L-lysine, L-
arginine, and ornithine, increased after whole grain consumption. 
Additionally, essential amino acids, such as phenylalanine and tyrosine, also 
increased after whole grain consumption. L-arginine is a cationic amino acid 
involved in several key metabolic processes and might improve postprandial 
glycemia, insulin sensitivity, hypertension, visceral obesity, endothelial 
dysfunction and inflammation (Lucotti et al., 2009; Morris, 2006). Thus, the 
beneficial effects of whole grain on CVD onset and progression might be 
partially explained by mechanisms involving several changes in plasma 
amino acid concentrations. Similarly, the diet enriched with whole grains 
increased betaine compounds in fasting plasma. Betaine enhances carnitine 
metabolism, and because carnitine is essential for transporting long-chain 
fatty acids into the mitochondria for energy production via β-oxidation, a link 
between betaine and lipid metabolism has been suggested (Pekkinen et al., 
2013). Betaine homeostasis could be essential in terms of beneficial health 
implications related to whole grain consumption. In addition, after fatty fish 
consumption there was an observed effect on the endogenous lipid profile. 
We observed an increase in PUFA-containing lipids, which have been 
receiving attention because of their role as intracellular signaling molecules 
(Picq et al., 2010). All identified molecular biomarkers of endogenous 
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metabolism, were involved in the beneficial effect of the healthy Nordic diet 
on the development of CVDs.  
Related to Study 3, we assessed the impact of a dietary intervention 
supplemented with a VOO or two different functional VOOs enriched with 
their own PC or complemented with thyme PC on HDL protein cargo. The 
study was conducted in hypercholesterolemic subjects of the Mediterranean 
area by applying a quantitative proteomic approach. Our results confirm the 
proposal that an intervention with different VOOs rich in PC remodels the 
HDL proteome changing the expression of different proteins with biological 
functions directly related to the cardioprotective activity of the HDL particle. 
Notably, although specific changes in the HDL protein cargo were observed 
after each intervention, the majority of the observed protein expression 
modifications were common after the three VOOs consumed. This result 
caused us to consider the effects of the fatty acid composition and the PC of 
the common matrix of the three VOOs tested on HDL remodeling. Proteins 
related to cholesterol homeostasis, protection against oxidation and blood 
coagulation were up-regulated after the interventions, whereas proteins 
involved in acute-phase response, lipid transport, and immune response 
were down-regulated. The IPA analysis also demonstrated the effect of 
certain signaling pathways after OO phenolic compounds consumption thus 
conferring cardioprotective properties. In this study, we observed how PC 
from OO are involved in regulating the transcription of specific genes, and 
consequently, certain proteins present in the HDL particle were up- or down-
regulated, thus inducing an improvement of HDL cardioprotective properties. 
The use of proteomics and new bioinformatics tools for data mining and 
biological interpretation such as IPA, allowed us to better understand the 
relation between the intake of VOO PC and the functionality of the HDL 
particle and to discover new therapeutic targets. 
With the results derived from the three presented studies, we can confirm 
that the use of nutritional biomarkers is a necessary and useful tool for 
assessing the effects of dietary bioactive compounds on CVDs. In addition, 
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the use of omic sciences, such as metabolomics and proteomics, within the 
concept of foodomics, add relevant information to the discovery of new 
nutritional and molecular biomarkers, which assist us in evaluating food 
bioactivity and food effects on human health and on disease prevention. 
Metabolomics and proteomics allow us to better understand the biology of 
CVDs and the effects of the diet on CVD onset and progression, providing 
an integrated view of biological systems (Figure 11). 
 
Figure 11. Approaches used for assessing the effects of dietary bioactive compounds on 
CVDs. 
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Future outlook: 
Validating and verifying the usefulness and the applicability of fasting plasma 
hippuric acid, glucuronidated alk(en)ylresorcinols and CMPF metabolites as 
potential biomarkers for bilberries whole grain, and fatty fish dietary intake, 
respectively, in further nutritional studies and with other populations is of 
considerable interest. Likewise, assessing whether these nutritional 
biomarkers are involved in the reduction of molecular biomarkers related to 
CVDs is of important clinical relevance. Moreover, studying the specific 
mechanisms of action of the endogen metabolism biomarkers discovered 
using in vitro studies is necessary. Finally, one more step that should be 
performed is to determine the activity and functionality of some of the HDL-
associated proteins to define whether the observed expression changes are 
relevant for the biological processes involved in CVDs.  
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1. Urinary TPE increased with age due to an increase in the 
consumption of vegetables, fruits, and coffee, and to a moderate 
intake of fermented beverages. Moreover, a higher urinary TPE is 
associated with a decrease in oxidative stress biomarkers, which may 
reflect an attenuation of oxidative damage in healthy individuals.  
2. The beneficial effects of a dietary intake rich in vegetables and 
moderate red wine on healthy individuals, could potentially be 
explained by the attenuation of oxidative damage associated with 
these typical food items of the Mediterranean diet, which are rich in 
polyphenols. 
3. A non-targeted metabolite approach based on LC-MS is an efficient 
technique in the discovery of specific novel nutritional biomarkers and 
in reporting metabolic alterations in fasting plasma after dietary 
interventions. 
4. Fasting plasma CMPF, glucuronidated alk(en)ylresorcinols and 
hippuric acid are suggested as novel candidate biomarkers of fatty 
fish, whole grain and bilberry consumption, respectively, because 
these candidates present a strong positive correlation with the 
proposed consumed foods. 
5. Alterations in molecular biomarkers of endogenous metabolism, such 
as PUFA-containing lipids, amino acids and betaine metabolites, 
could explain the effect of whole grains, fatty fish and bilberry 
consumption on metabolic pathways, thus indicating the potential 
beneficial effects of a healthy Nordic diet. 
6. A quantitative proteomics approach based on iTRAQ-LC-MS/MS 
potentially can better elucidate the effects of dietary interventions with 
OOs rich in PC on the complex structure of the HDL protein cargo. 
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7. The consumption of VOO or phenol-enriched VOOs has an impact on 
the HDL proteome in a cardioprotective mode that could enhance 
HDL functionality by up-regulating proteins related to cholesterol 
homeostasis, protection against oxidation and blood coagulation while 
down-regulating proteins involved in acute-phase response, lipid 
transport, and immune responses.  
8. The common protein expression modifications reported after the 
consumption of the three VOOs indicate a major effect of the fatty acid 
and PC composition present in the common matrix of these VOOs on 
HDL remodeling. 
OVERALL CONCLUSION 
The use of nutritional biomarkers is a useful tool in assessing the 
mechanisms of action and the biological effects of dietary bioactive 
compounds on CVD development. Thus, the use of omic sciences, such as 
metabolomics and proteomics, add relevant information to the discovery of 
novel nutritional and molecular biomarkers, which assist us in evaluating 
food bioactivity and food effects on human health and on disease 
prevention. 
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